[
  {
    "term": "pT3 (kidney)",
    "definition": "pT3 (kidney) denotes a stage of kidney cancer characterized by the tumor's invasion into adjacent tissues or structures without metastasizing to remote locations.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3 (kidney)",
    "definition": "pT3 (kidney) is a classification indicating that the kidney tumor has infiltrated nearby tissues or structures, yet has not disseminated to distant areas.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3 (kidney)",
    "definition": "pT3 (kidney) refers to a classification of kidney cancer where the tumor has grown into surrounding tissues or structures but has not spread to distant sites.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3 (kidney)",
    "definition": "pT3 (kidney) signifies a category of kidney cancer in which the tumor extends into surrounding tissues or structures while remaining localized and not spreading to distant sites.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "GenePattern module KMeansClustering",
    "definition": "In GenePattern, the KMeansClustering module functions as a computational tool that partitions a group of data points into distinct clusters based on their similarities, applying the K-means algorithm to minimize the variance found within each cluster.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KMeansClustering",
    "definition": "The GenePattern module KMeansClustering is a computational tool that groups a set of data points into distinct clusters based on their similarities, using the K-means algorithm to minimize the variance within each cluster.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KMeansClustering",
    "definition": "The KMeansClustering component of GenePattern serves as a computational tool that organizes a dataset into unique clusters according to their similarities, utilizing the K-means algorithm to decrease variance within the clusters.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KMeansClustering",
    "definition": "The KMeansClustering module in GenePattern is a computational resource that categorizes a collection of data points into separate clusters by analyzing their similarities, employing the K-means algorithm to reduce the variance within each cluster.",
    "type": "GenePattern software"
  },
  {
    "term": "Stage IIIA (FIGO)",
    "definition": "Stage IIIA (FIGO) denotes a category of gynecological cancer characterized by tumor invasion into the pelvic sidewall or the lower third of the vagina, while remaining confined to the abdominal cavity and distant organs.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIIA (FIGO)",
    "definition": "Stage IIIA (FIGO) indicates a level of gynecological cancer in which the malignancy has extended to the pelvic sidewall or the lower third of the vagina without involvement of the abdominal cavity or remote organs.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIIA (FIGO)",
    "definition": "Stage IIIA (FIGO) is a classification of gynecological cancer that signifies the tumor's spread to the pelvic sidewall or the lower third of the vagina, but it has not metastasized to the abdominal cavity or other distant sites.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIIA (FIGO)",
    "definition": "Stage IIIA (FIGO) refers to a classification of gynecological cancer where the tumor has spread to the pelvic sidewall or lower third of the vagina but not to the abdominal cavity or distant organs.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "angstrom",
    "definition": "An angstrom represents a unit of length that is the same as 10^-10 meters.",
    "type": "length unit"
  },
  {
    "term": "angstrom",
    "definition": "The angstrom denotes a length unit that corresponds to 10 raised to the minus 10 meters.",
    "type": "length unit"
  },
  {
    "term": "angstrom",
    "definition": "The angstrom is a length measurement equivalent to 10 to the power of negative 10 meters.",
    "type": "length unit"
  },
  {
    "term": "angstrom",
    "definition": "The angstrom is a unit of length equal to 10−10 m",
    "type": "length unit"
  },
  {
    "term": "angstrom",
    "definition": "The unit, equivalent to one ten-billionth of a meter, one hundred-millionth of a centimeter, 0.1 nanometer, or 100 picometers, is named after the Swedish physicist Anders Jonas Ångström (1814–1874); it was initially written with Swedish characters as Ångström and later as ångström, though the latter form is now infrequently found in English literature, with some American dictionaries recognizing only the angstrom spelling.",
    "type": "length unit"
  },
  {
    "term": "angstrom",
    "definition": "This unit, which measures one ten-billionth of a meter, one hundred-millionth of a centimeter, 0.1 nanometer, or 100 picometers, is named after the Swedish physicist Anders Jonas Ångström (1814–1874)",
    "type": "length unit"
  },
  {
    "term": "angstrom",
    "definition": "that is, one ten-billionth of a metre, a hundred-millionth of a centimetre, 0.1 nanometre, or 100 picometres. The unit is named after the Swedish physicist Anders Jonas Ångström (1814–1874). It was originally spelled with Swedish letters, as Ångström and later as ångström. The latter spelling is still listed in some dictionaries, but is now rare in English texts. Some popular US dictionaries list only the spelling angstrom.",
    "type": "length unit"
  },
  {
    "term": "nanometer",
    "definition": "A nanometre, referred to as a nanometer, is a length unit in the International System of Units (SI) that corresponds to one billionth of a meter (0.000000001 m) and is equal to 1000 picometres, which can be written scientifically as 1 × 10−9 m",
    "type": "length unit"
  },
  {
    "term": "nanometer",
    "definition": "The nanometre, also known as nanometer, is a metric length measurement in the International System of Units (SI) that is equivalent to one billionth of a meter (0.000000001 m) or 1000 picometres, and can be represented in scientific notation as 1 × 10−9 m or as 1/1,000,000,000 m.",
    "type": "length unit"
  },
  {
    "term": "nanometer",
    "definition": "The nanometre, or nanometer, is a unit of length in the International System of Units (SI), equal to one billionth or one thousand million of a meter (0.000000001 m) and to 1000 picometres. One nanometre can be expressed in scientific notation as 1 × 10−9 m and as ⁠1/1000000000⁠ m.",
    "type": "length unit"
  },
  {
    "term": "pT1 (ovary)",
    "definition": "pT1 (ovary) denotes a categorization signifying that a tumor located in the ovary is localized within the organ and has not metastasized outside of it.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1 (ovary)",
    "definition": "pT1 (ovary) describes a staging that shows a tumor in the ovary is limited to the organ itself without any dissemination to surrounding areas.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1 (ovary)",
    "definition": "pT1 (ovary) is a classification that indicates a tumor in the ovary remains restricted to the organ and has not extended beyond its boundaries.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1 (ovary)",
    "definition": "pT1 (ovary) refers to a classification indicating that a tumor in the ovary is confined to the organ itself and has not spread beyond it.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "Stage 1 (FIGO)",
    "definition": "Stage 1 (FIGO) denotes the earliest phase of gynecological malignancies, characterized by the presence of cancer solely within the original organ, with no involvement of adjacent tissues or lymphatic nodes.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 1 (FIGO)",
    "definition": "Stage 1 (FIGO) indicates the primary level of gynecological tumors, in which the cancer remains localized to its site of origin and has not invaded surrounding tissues or lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 1 (FIGO)",
    "definition": "Stage 1 (FIGO) refers to the initial stage of gynecological cancers, where the disease is confined to the organ of origin without any spread to nearby tissues or lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 1 (FIGO)",
    "definition": "Stage 1 (FIGO) signifies the first stage of gynecological cancers, where the tumor is restricted to its originating organ and shows no dissemination to nearby tissues or lymphatic systems.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "hertz",
    "definition": "The hertz is the SI unit for frequency, equivalent to one cycle per second, expressed in SI base units as 1/s or s",
    "type": "frequency unit"
  },
  {
    "term": "hertz",
    "definition": "The hertz is the unit of frequency in the International System of Units (SI), often described as being equivalent to one event per second. The hertz is an SI derived unit whose formal expression in terms of SI base units is 1/s or s−1, meaning that one hertz is one per second or the reciprocal of one second. It is used only in the case of periodic events. It is named after Heinrich Rudolf Hertz (1857–1894), the first person to provide conclusive proof of the existence of electromagnetic waves. For high frequencies, the unit is commonly expressed in multiples: kilohertz (kHz), megahertz (MHz), gigahertz (GHz), terahertz (THz).",
    "type": "frequency unit"
  },
  {
    "term": "hertz",
    "definition": "The hertz, a frequency measurement in the International System of Units (SI), is defined as one occurrence per second and is represented in SI base units as 1/s or s−1, indicating that one hertz corresponds to the reciprocal of one second; it applies exclusively to periodic phenomena and is named in honor of Heinrich Rudolf Hertz (1857–1894), who first demonstrated the existence of electromagnetic waves, with higher frequencies often denoted in multiples such as kilohertz (kHz), megahertz (MHz), gigahertz (GHz), and terahertz (THz).",
    "type": "frequency unit"
  },
  {
    "term": "Waters",
    "definition": "\"Waters can denote:\"",
    "type": "manufacturer"
  },
  {
    "term": "Waters",
    "definition": "\"Waters could signify:\"",
    "type": "manufacturer"
  },
  {
    "term": "Waters",
    "definition": "\"Waters might indicate:\"",
    "type": "manufacturer"
  },
  {
    "term": "Waters",
    "definition": "Waters may refer to:",
    "type": "manufacturer"
  },
  {
    "term": "pT3b (ovary)",
    "definition": "In the pT3b (ovary) category, ovarian cancer is defined by the tumor's infiltration into the peritoneum beyond the pelvic area, while remaining confined to the local region without affecting distant organs, reflecting a more advanced local disease state.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3b (ovary)",
    "definition": "The classification pT3b (ovary) indicates an advanced stage of ovarian cancer in which the tumor has metastasized to the peritoneum outside the pelvic region, yet has not spread to distant sites.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3b (ovary)",
    "definition": "pT3b (ovary) denotes a stage of ovarian cancer characterized by tumor extension to the peritoneal cavity beyond the pelvis without metastasis to distant organs, signifying advanced local progression.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3b (ovary)",
    "definition": "pT3b (ovary) refers to a classification of ovarian cancer where the tumor has spread to the peritoneum outside the pelvis but not to distant organs, indicating advanced local disease.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2 (kidney)",
    "definition": "The term pT2 (kidney) indicates a tumor classification where the kidney tumor has breached the renal capsule or perinephric fat, but has not extended to nearby lymph nodes or remote sites.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2 (kidney)",
    "definition": "pT2 (kidney) denotes a staging category that signifies a kidney tumor has penetrated the renal capsule or surrounding perinephric fat, yet remains confined without metastasizing to adjacent lymph nodes or distant locations.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2 (kidney)",
    "definition": "pT2 (kidney) is a classification that describes a kidney tumor which has infiltrated the renal capsule or perinephric fat, while not having metastasized to nearby lymph nodes or other distant areas.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2 (kidney)",
    "definition": "pT2 (kidney) refers to a classification indicating that a kidney tumor has invaded the renal capsule or perinephric fat but has not spread to nearby lymph nodes or distant sites.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "Thermo",
    "definition": "The term Thermo may indicate: Adobe Thermo, a design application for Rich Internet Application interfaces by Adobe Systems; heat, defined as energy movement",
    "type": "manufacturer"
  },
  {
    "term": "Thermo",
    "definition": "Thermo can denote: Adobe Thermo, a tool for designers to develop user interfaces for Rich Internet Applications by Adobe Systems; heat, which is the energy exchanged between systems through thermal interaction; Thermo Fisher Scientific, a company specializing in healthcare equipment; Thermo, a town located in Aetolia-Acarnania, Greece; thermodynamics, the area of physical science that studies heat and its connections to other energy forms and work; a thermos, a vessel designed to insulate and maintain the temperature of its contents; and Thermo (journal), an academic publication from MDPI.",
    "type": "manufacturer"
  },
  {
    "term": "Thermo",
    "definition": "Thermo may refer to:Adobe Thermo, a designers' tool for creating the user interface for Rich Internet Application by Adobe Systems Heat, energy transferred from one system to another by thermal interaction Thermo Fisher Scientific, a healthcare equipment company Thermo, Greece, a town in Aetolia-Acarnania, Greece Thermodynamics, the branch of physical science concerned with heat and its relation to other forms of energy and work Thermos, an insulating storage vessel which keeps its contents hotter or cooler than its surroundings Thermo (journal), an academic journal published by MDPI",
    "type": "manufacturer"
  },
  {
    "term": "cM0 (ovary)",
    "definition": "cM0 (ovary) denotes that there is no indication of metastatic involvement of the ovaries in an individual diagnosed with cancer.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "cM0 (ovary)",
    "definition": "cM0 (ovary) indicates that there is no evidence of distant metastasis to the ovaries in a patient with cancer.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "cM0 (ovary)",
    "definition": "cM0 (ovary) reflects that there is no proof of distant cancer spread to the ovaries in a patient suffering from malignancy.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "cM0 (ovary)",
    "definition": "cM0 (ovary) signifies the absence of any signs of metastatic spread to the ovaries in a cancer patient.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3a (ovary)",
    "definition": "pT3a (ovary) denotes a stage of ovarian cancer characterized by the tumor's extension beyond the ovaries into the peritoneal cavity without involvement of other organs, signifying a more progressed form of the illness.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3a (ovary)",
    "definition": "pT3a (ovary) indicates a classification of ovarian cancer where the tumor has metastasized to the peritoneum but has not yet affected other organs, marking a more severe progression of the disease.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3a (ovary)",
    "definition": "pT3a (ovary) is a designation for ovarian cancer in which the tumor has invaded the peritoneum while remaining confined to the ovaries and not affecting additional organs, reflecting a later stage of the condition.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3a (ovary)",
    "definition": "pT3a (ovary) refers to a classification of ovarian cancer where the tumor has spread beyond the ovaries to the peritoneum but not to other organs, indicating a more advanced stage of the disease.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "Abbott",
    "definition": "Abbott could denote:",
    "type": "manufacturer"
  },
  {
    "term": "Abbott",
    "definition": "Abbott may refer to:",
    "type": "manufacturer"
  },
  {
    "term": "Abbott",
    "definition": "Abbott might indicate:",
    "type": "manufacturer"
  },
  {
    "term": "Abbott",
    "definition": "The term Abbott might signify:",
    "type": "manufacturer"
  },
  {
    "term": "pT1b (ovary)",
    "definition": "pT1b (ovary) denotes a category of ovarian cancer characterized by tumor invasion that has affected one or both ovaries while remaining limited to the ovaries without impacting adjacent pelvic tissues.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1b (ovary)",
    "definition": "pT1b (ovary) describes a subtype of ovarian cancer where the tumor has invaded and spread to one or both ovaries, yet is still localized to the ovaries without involving surrounding pelvic structures.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1b (ovary)",
    "definition": "pT1b (ovary) is a designation for ovarian cancer that signifies the presence of an invasive tumor that has extended to one or both ovaries but is restricted to the ovaries without affecting other pelvic organs.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1b (ovary)",
    "definition": "pT1b (ovary) refers to a classification of ovarian cancer indicating that the tumor is invasive and has spread to one or both ovaries but is confined to the ovaries without involvement of other pelvic structures.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "Stage 2A (FIGO)",
    "definition": "Stage 2A (FIGO) denotes a category of cervical cancer in which the malignancy has extended from the cervix to the upper two-thirds of the vagina, without invading the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2A (FIGO)",
    "definition": "Stage 2A (FIGO) describes a level of cervical cancer where the tumor has progressed from the cervix to the upper two-thirds of the vagina, but has not yet reached the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2A (FIGO)",
    "definition": "Stage 2A (FIGO) indicates a classification of cervical cancer characterized by the tumor's invasion beyond the cervix into the upper two-thirds of the vagina, while sparing the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2A (FIGO)",
    "definition": "Stage 2A (FIGO) refers to a classification of cervical cancer where the tumor has spread beyond the cervix to the upper two-thirds of the vagina but not to the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "cM1 (lung)",
    "definition": "cM1 (lung) denotes a category of metastatic cancer signifying that the malignancy has disseminated to the lungs from its primary location.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1 (lung)",
    "definition": "cM1 (lung) is a designation for metastatic cancer that indicates the disease has extended to the lungs from where it initially developed.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1 (lung)",
    "definition": "cM1 (lung) refers to a classification of metastatic cancer indicating that the disease has spread to the lungs from its original site.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1 (lung)",
    "definition": "cM1 (lung) represents a classification for metastatic cancer, indicating that the cancer has migrated to the lungs from its original source.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1a (kidney)",
    "definition": "The classification pT1a (kidney) indicates a type of kidney cancer where the tumor does not exceed 7 centimeters and is contained within the kidney, without any dissemination to nearby tissues or lymph nodes.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT1a (kidney)",
    "definition": "pT1a (kidney) denotes a category of kidney cancer characterized by a tumor measuring 7 centimeters or less, which remains localized within the kidney and has not invaded adjacent tissues or lymph nodes.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT1a (kidney)",
    "definition": "pT1a (kidney) is a designation for kidney cancer in which the tumor is 7 centimeters or less in size and is restricted to the kidney, with no involvement of surrounding tissues or lymphatic nodes.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT1a (kidney)",
    "definition": "pT1a (kidney) refers to a classification of kidney cancer where the tumor is 7 centimeters or smaller and is confined to the kidney without any spread to nearby tissues or lymph nodes.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "XML",
    "definition": "Extensible Markup Language (XML) is a markup language and file format for storing, transmitting, and reconstructing data. It defines a set of rules for encoding documents in a format that is both human-readable and machine-readable. The World Wide Web Consortium's XML 1.0 Specification of 1998 and several other related specifications—all of them free open standards—define XML.",
    "type": "data format specification"
  },
  {
    "term": "XML",
    "definition": "The Extensible Markup Language (XML) serves as a markup language and file format designed for the storage, transfer, and reconstruction of data, establishing guidelines for encoding documents in a manner that is accessible to both humans and machines; the XML 1.0 Specification from the World Wide Web Consortium, released in 1998, along with various other associated specifications, all of which are open standards available at no cost, delineate XML.",
    "type": "data format specification"
  },
  {
    "term": "XML",
    "definition": "XML, or Extensible Markup Language, is a markup language and file format utilized for the purposes of data storage, transmission, and reconstruction, outlining a framework for encoding documents that can be easily interpreted by both people and computers; the XML 1.0 Specification from the World Wide Web Consortium,",
    "type": "data format specification"
  },
  {
    "term": "kilogram",
    "definition": "In SI, the kilogram is the standard unit of mass, corresponding to one thousand grams and indicated by the symbol kg, with its name originating from the combination of the metric prefix kilo- and the unit gram.",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "In the International System of Units (SI), the kilogram is recognized as the primary unit of mass, which is equal to one thousand grams and represented by the symbol kg; the term \"kilogram\" is created by merging the prefix kilo- with the word gram.",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "It is commonly abbreviated as \"kilo.\"",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "It is informally referred to as \"kilo.\"",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "It is often condensed to \"kilo.\"",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "The kilogram is the base unit of mass in the International System of Units (SI), equal to one thousand grams. It has the unit symbol kg. The word \"kilogram\" is formed from the combination of the metric prefix kilo- and gram",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "The kilogram serves as the fundamental unit of mass in the International System of Units (SI), equivalent to one thousand grams, denoted by the symbol kg, and its name is derived from the metric prefix kilo- combined with the term gram.",
    "type": "mass unit"
  },
  {
    "term": "kilogram",
    "definition": "it is colloquially shortened to \"kilo\".",
    "type": "mass unit"
  },
  {
    "term": "ambidexterous",
    "definition": "Ambidexterity is defined as the skill to handle both the right and left hand with equal ease; when talking about objects, it implies that they are equally accommodating for users",
    "type": "categorical label"
  },
  {
    "term": "ambidexterous",
    "definition": "Ambidexterity is the ability to use both the right and left hand equally well. When referring to objects, the term indicates that the object is equally suitable for right-handed and left-handed people. When referring to humans, it indicates that a person has no marked preference for the use of the right or left hand.",
    "type": "categorical label"
  },
  {
    "term": "ambidexterous",
    "definition": "Ambidexterity refers to the capability of utilizing both hands with equal proficiency; in the context of objects, it signifies that they are designed to be equally functional for both right-handed and left-handed individuals, while in relation to people, it denotes a lack of strong inclination towards either hand.",
    "type": "categorical label"
  },
  {
    "term": "ambidexterous",
    "definition": "The term ambidexterity describes the skill of effectively using both hands to the same degree; when applied to items, it means they are appropriate for both right- and left-handed users, and when discussing individuals, it signifies an absence of a dominant hand preference.",
    "type": "categorical label"
  },
  {
    "term": "pN2a (colon)",
    "definition": "The term pN2a (colon) describes a pathological category indicating that the cancer has metastasized to 4 to 6 lymph nodes located in the colon region.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN2a (colon)",
    "definition": "pN2a (colon) denotes the pathological staging that signifies the presence of cancer metastasis to 4 to 6 nearby lymph nodes in the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN2a (colon)",
    "definition": "pN2a (colon) is a pathological classification that indicates the dissemination of cancer to 4 to 6 regional lymph nodes within the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN2a (colon)",
    "definition": "pN2a (colon) refers to the pathological classification indicating that cancer has spread to 4 to 6 regional lymph nodes in the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "ready for release",
    "definition": "\"Approved for distribution\" denotes a status in which a biological product, including a drug or vaccine, has successfully passed all requisite testing and quality control protocols, establishing its safety, efficacy, and compliance with regulatory standards for release and application.",
    "type": "curation status specification"
  },
  {
    "term": "ready for release",
    "definition": "\"Prepared for launch\" signifies a phase in which a biological product, such as a pharmaceutical or vaccine, has finished all essential assessments and quality checks, affirming its safety, performance, and conformity with regulatory guidelines for dissemination and utilization.",
    "type": "curation status specification"
  },
  {
    "term": "ready for release",
    "definition": "\"Ready for distribution\" indicates a condition where a biological product, like a medication or vaccine, has undergone all required evaluations and quality assurance processes, validating its safety, effectiveness, and adherence to regulatory requirements for release and application.",
    "type": "curation status specification"
  },
  {
    "term": "ready for release",
    "definition": "\"Ready for release\" refers to a state in which a biological product, such as a drug or vaccine, has completed all necessary testing and quality control measures, confirming its safety, efficacy, and compliance with regulatory standards for distribution and use.",
    "type": "curation status specification"
  },
  {
    "term": "Stage IVB (FIGO)",
    "definition": "Stage IVB (FIGO) denotes an advanced phase of cancer in which the malignancy has disseminated to distant organs or tissues, such as the liver, lungs, or other non-adjacent locations, without consideration of the primary tumor's dimensions or lymph node involvement.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IVB (FIGO)",
    "definition": "Stage IVB (FIGO) indicates an advanced cancer stage characterized by the metastasis of the disease to remote organs or tissues, including the liver, lungs, or other non-contiguous areas, irrespective of the primary tumor's size or lymph node status.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IVB (FIGO)",
    "definition": "Stage IVB (FIGO) refers to the advanced stage of cancer where the disease has spread to distant organs or tissues, such as the liver, lungs, or other non-adjacent sites, regardless of the size of the primary tumor or lymph node involvement.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IVB (FIGO)",
    "definition": "Stage IVB (FIGO) signifies a late stage of cancer where the illness has metastasized to far-off organs or tissues, including the liver, lungs, or other sites not directly connected,",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "nanogram",
    "definition": "A nanogram is defined as one billionth of a gram and is typically used to gauge extremely small amounts of compounds in biomedical research.",
    "type": "mass unit"
  },
  {
    "term": "nanogram",
    "definition": "A nanogram is one billionth of a gram, commonly used to measure very small quantities of substances in biomedical contexts.",
    "type": "mass unit"
  },
  {
    "term": "nanogram",
    "definition": "A nanogram represents one billionth of a gram and is frequently utilized for quantifying minute amounts of materials in biomedical applications.",
    "type": "mass unit"
  },
  {
    "term": "nanogram",
    "definition": "A nanogram, equivalent to one billionth of a gram, is often employed to assess tiny quantities of substances in the field of biomedicine.",
    "type": "mass unit"
  },
  {
    "term": "term imported",
    "definition": "\"Term imported\" denotes a concept or terminology that has been sourced externally and integrated into a particular context or database for purposes of classification or description.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "term imported",
    "definition": "\"Term imported\" refers to a concept or term that has been brought into a specific context or database from an external source for use in classification or description.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "term imported",
    "definition": "The expression \"term imported\" indicates a concept or term that has been introduced into a certain context or database from an external origin for the purpose of classification or description.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "term imported",
    "definition": "The phrase \"term imported\" signifies a concept or term that has been acquired from an outside source and incorporated into a specific context or database for classification or descriptive use.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "picogram",
    "definition": "In order to compare different scales of mass, the following lists present mass values ranging from 10−67 kg to 1052 kg, where the graviton represents the smallest mass and the observable universe the largest; usually, an increase in mass corresponds to an increase in weight (see mass versus weight), especially when the objects are under the influence of the same gravitational field.",
    "type": "mass unit"
  },
  {
    "term": "picogram",
    "definition": "To facilitate the comparison of various scales of mass, the subsequent lists outline mass ranges from 10−67 kg to 1052 kg, with a graviton being the least massive entity and the observable universe being the most massive; generally, an object's mass correlates with its weight (refer to mass versus weight), particularly when the objects experience identical gravitational field strengths.",
    "type": "mass unit"
  },
  {
    "term": "picogram",
    "definition": "To help compare different orders of magnitude, the following lists describe various mass levels between 10−67 kg and 1052 kg. The least massive thing listed here is a graviton, and the most massive thing is the observable universe. Typically, an object having greater mass will also have greater weight (see mass versus weight), especially if the objects are subject to the same gravitational field strength.",
    "type": "mass unit"
  },
  {
    "term": "nanomolar",
    "definition": "As an illustration, the hydronium ion [H3O+] has a concentration of 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "nanomolar",
    "definition": "For instance, the concentration of the hydronium ion [H3O+] is 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "nanomolar",
    "definition": "Known as amount-of-substance concentration or molarity, molar concentration indicates the number of moles of solute contained in one liter of a solution, serving as a measure of the concentration of a chemical species, particularly",
    "type": "concentration unit"
  },
  {
    "term": "nanomolar",
    "definition": "Molar concentration (also called amount-of-substance concentration or molarity) is the number of moles of solute per liter of solution. Specifically, It is a measure of the concentration of a chemical species, in particular, of a solute in a solution, in terms of amount of substance per unit volume of solution. In chemistry, the most commonly used unit for molarity is the number of moles per liter, having the unit symbol mol/L or mol/dm3 (1000 mol/m3) in SI units. Molar concentration is often depicted with square brackets around the substance of interest",
    "type": "concentration unit"
  },
  {
    "term": "nanomolar",
    "definition": "Molar concentration, known as amount-of-substance concentration or molarity, refers to the quantity of solute in moles present in one liter of solution, and it quantifies the concentration of a chemical species, specifically a solute, based on the amount of substance per volume of solution; in chemistry, this is typically expressed in moles per liter (mol/L or mol/dm³), equivalent to 1000 mol/m³ in SI units, and is often represented with square brackets surrounding the relevant substance.",
    "type": "concentration unit"
  },
  {
    "term": "nanomolar",
    "definition": "To illustrate, the concentration of the hydronium ion [H3O+] is measured at 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "nanomolar",
    "definition": "for example with the hydronium ion [H3O+] = 4.57 x 10-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "pT2 (colon)",
    "definition": "The classification pT2 (colon) in cancer staging indicates that the tumor has breached the muscularis propria layer of the colon, yet has not extended beyond the serosa or into adjacent anatomical structures.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT2 (colon)",
    "definition": "pT2 (colon) denotes a cancer staging category that signifies the tumor has infiltrated the muscularis propria of the colon without breaching the serosa or extending into nearby tissues.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT2 (colon)",
    "definition": "pT2 (colon) is a cancer staging designation that indicates the tumor has encroached upon the muscularis propria layer of the colon while remaining confined to this layer, without invading the serosa or surrounding structures.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT2 (colon)",
    "definition": "pT2 (colon) refers to a classification in cancer staging indicating that the tumor has invaded the muscularis propria layer of the colon but has not penetrated through the serosa or into adjacent structures.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "molar",
    "definition": "Molar can denote various concepts including: Molar (tooth), a type of tooth present in mammals; Molar (grape), an alternative name for the Spanish wine grape known as Listan Negro; Molar (unit), a measurement of concentration defined as one mole per liter; Molar quantities, which encompass terms like molar mass and molar volume; El Molar, Tarragona, a village located in the Priorat comarca of Tarragona province in Catalonia, Spain; and El Molar, Madrid, a town situated in the northern part of the Community of Madrid along the route to Burgos, past San Agustín de Guadalix.",
    "type": "concentration unit"
  },
  {
    "term": "molar",
    "definition": "Molar may refer to:Molar (tooth), a kind of tooth found in mammals Molar (grape), another name for the Spanish wine grape Listan Negro Molar (unit), a unit of concentration equal to 1 mole per litre Molar quantities, such as molar mass, molar volume, etc. El Molar, Tarragona, a village in the comarca (county) of Priorat, province of Tarragona in the autonomous region of Catalonia, Spain El Molar, Madrid, a town in the north of the Community of Madrid in the road to Burgos, after San Agustín de Guadalix",
    "type": "concentration unit"
  },
  {
    "term": "molar",
    "definition": "The term \"Molar\" can signify several things, including: Molar (",
    "type": "concentration unit"
  },
  {
    "term": "GenePattern CART",
    "definition": "GenePattern CART is a bioinformatics tool that applies classification and regression tree methods to evaluate and illustrate complicated biological data for predictive modeling in the field of genomics.",
    "type": "CART"
  },
  {
    "term": "GenePattern CART",
    "definition": "GenePattern CART is a computational resource that utilizes tree-based algorithms for classification and regression to assess and depict complex biological information for forecasting in genomics.",
    "type": "CART"
  },
  {
    "term": "GenePattern CART",
    "definition": "GenePattern CART is a computational tool that uses classification and regression tree algorithms to analyze and visualize complex biological data for predictive modeling in genomics.",
    "type": "CART"
  },
  {
    "term": "GenePattern CART",
    "definition": "GenePattern CART is a software application that employs classification and regression tree techniques to interpret and represent intricate biological datasets for predictive analysis in genomics.",
    "type": "CART"
  },
  {
    "term": "Ambion",
    "definition": "Ambion is a brand known for producing high-quality reagents and tools for molecular biology research, particularly in the areas of RNA analysis and gene expression.",
    "type": "manufacturer"
  },
  {
    "term": "Ambion",
    "definition": "Ambion is a distinguished brand celebrated for manufacturing high-grade reagents and resources for molecular biology investigations, particularly in RNA analysis and gene expression studies.",
    "type": "manufacturer"
  },
  {
    "term": "Ambion",
    "definition": "Ambion is a renowned brand recognized for its production of premium reagents and instruments utilized in molecular biology studies, especially concerning RNA analysis and gene expression.",
    "type": "manufacturer"
  },
  {
    "term": "Ambion",
    "definition": "Ambion is a well-regarded brand that specializes in creating top-notch reagents and tools for research in molecular biology, with a focus on RNA analysis and gene expression.",
    "type": "manufacturer"
  },
  {
    "term": "cM1a (lung)",
    "definition": "cM1a (lung) denotes a category of metastatic cancer characterized by the spread of the disease to the lungs without involvement of other distant locations in the body.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1a (lung)",
    "definition": "cM1a (lung) indicates a type of metastatic cancer in which the cancer has metastasized to the lungs but has not disseminated to other remote sites in the body.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1a (lung)",
    "definition": "cM1a (lung) is a designation for metastatic cancer indicating that the malignancy has reached the lungs while remaining confined to the body without affecting other distant areas.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1a (lung)",
    "definition": "cM1a (lung) refers to a classification of metastatic cancer where the disease has spread to the lungs but not to other distant sites in the body.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "defined class",
    "definition": "A defined class consists of a distinct collection of entities that exhibit similar features or qualities, which facilitates their grouping for investigation or analysis.",
    "type": "denotator type"
  },
  {
    "term": "defined class",
    "definition": "A defined class is a specific group of entities that share common characteristics or properties, allowing them to be categorized together for analysis or study.",
    "type": "denotator type"
  },
  {
    "term": "defined class",
    "definition": "A defined class is an identifiable group of entities that have common attributes or characteristics, making it possible to group them together for the purposes of study or analysis.",
    "type": "denotator type"
  },
  {
    "term": "defined class",
    "definition": "A defined class refers to a particular set of entities that possess shared traits or attributes, enabling their collective categorization for examination or research.",
    "type": "denotator type"
  },
  {
    "term": "Affymetrix",
    "definition": "Affymetrix has been rebranded as Applied Biosystems, a line of DNA microarray products marketed by Thermo Fisher Scientific, which traces its roots to an American biotech R&D and manufacturing firm of the same name.",
    "type": "material supplier"
  },
  {
    "term": "Affymetrix",
    "definition": "Affymetrix is now Applied Biosystems, a brand of DNA microarray products sold by Thermo Fisher Scientific that originated with an American biotechnology research and development and manufacturing company of the same name. The Santa Clara, California-based Affymetrix, Inc. now a part of Thermo Fisher Scientific was co-founded by Alex Zaffaroni and Stephen Fodor. Stephen Fodor and his group, based on their earlier development of methods to fabricate DNA microarrays using semiconductor manufacturing techniques.",
    "type": "material supplier"
  },
  {
    "term": "Affymetrix",
    "definition": "Once known as Affymetrix, the brand has transitioned to Applied Biosystems, a segment of Thermo Fisher Scientific that specializes in DNA microarray products, stemming from a biotechnology company established by Alex Zaffar",
    "type": "material supplier"
  },
  {
    "term": "Affymetrix",
    "definition": "The company formerly known as Affymetrix is now Applied Biosystems, a division of Thermo Fisher Scientific that offers DNA microarray products, and it originated from a biotechnology research and development firm co-founded by Alex Zaffaroni and Stephen Fodor in Santa Clara, California.",
    "type": "material supplier"
  },
  {
    "term": "Applied Biosystems",
    "definition": "Applied Biosystems is a brand within the Life Technologies division of Thermo Fisher Scientific, specializing in comprehensive systems for genetic analysis, encompassing both automated equipment and the necessary consumables.",
    "type": "manufacturer"
  },
  {
    "term": "Applied Biosystems",
    "definition": "Applied Biosystems is one of various brands under the Life Technologies brand of Thermo Fisher Scientific corporation. The brand is focused on integrated systems for genetic analysis, which include computerized machines and the consumables used within them.",
    "type": "manufacturer"
  },
  {
    "term": "Applied Biosystems",
    "definition": "The brand Applied Biosystems, part of Thermo Fisher Scientific's Life Technologies umbrella, concentrates on integrated genetic analysis systems that consist of both automated devices and their associated consumables.",
    "type": "manufacturer"
  },
  {
    "term": "Applied Biosystems",
    "definition": "Under the Life Technologies name of Thermo Fisher Scientific, Applied Biosystems offers a range of integrated systems designed for genetic analysis, featuring both electronic machinery and the consumable products utilized in these systems.",
    "type": "manufacturer"
  },
  {
    "term": "pT0 (ovary)",
    "definition": "pT0 (ovary) denotes that there is no sign of a primary tumor in the ovary, indicating that the ovarian tissue appears to be healthy or free from cancerous effects.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT0 (ovary)",
    "definition": "pT0 (ovary) indicates that there is no evidence of primary tumor in the ovary, suggesting that the ovarian tissue appears normal or unaffected by cancer.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT0 (ovary)",
    "definition": "pT0 (ovary) reflects that there is no indication of a primary tumor in the ovary, suggesting that the ovarian tissue looks normal or is not influenced by cancer.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT0 (ovary)",
    "definition": "pT0 (ovary) signifies the absence of any detectable primary tumor in the ovary, implying that the ovarian tissue seems to be normal or not impacted by cancer.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2 (lung)",
    "definition": "In lung cancer staging, pT2 (lung) indicates a tumor that exceeds 3 cm but is no more than 5 cm in size, which may involve the main bronchus or visceral ple",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2 (lung)",
    "definition": "The classification pT2 (lung) in lung cancer staging denotes a tumor size greater than 3 cm but less than or equal to 5 cm, which may impact the main bronchus or visceral pleura but does not extend to the chest wall or diaphragm.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2 (lung)",
    "definition": "pT2 (lung) designates a category in the staging of lung cancer that signifies a tumor measuring over 3 cm and up to 5 cm, potentially affecting the primary bronchus or the visceral pleura, yet without penetrating the chest wall or diaphragm.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2 (lung)",
    "definition": "pT2 (lung) refers to a classification in lung cancer staging indicating a tumor that is larger than 3 cm but not larger than 5 cm, and may involve the main bronchus or the visceral pleura, but does not invade the chest wall or diaphragm.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "mass percentage",
    "definition": "Mass percentage is the ratio of the mass of a specific component in a mixture to the total mass of the mixture, expressed as a percentage.",
    "type": "concentration unit"
  },
  {
    "term": "mass percentage",
    "definition": "The mass percentage indicates the fraction of the mass of a designated element in a mixture relative to the total mass of that mixture, expressed as a percentage.",
    "type": "concentration unit"
  },
  {
    "term": "mass percentage",
    "definition": "The mass percentage represents the proportion of the mass of a particular component within a mixture compared to the overall mass of the mixture, stated as a percentage.",
    "type": "concentration unit"
  },
  {
    "term": "mass percentage",
    "definition": "The ratio of the mass of a specific substance in a mixture to the total mass of the mixture, expressed as a percentage, is known as the mass percentage.",
    "type": "concentration unit"
  },
  {
    "term": "pT2a (lung)",
    "definition": "The classification pT2a (lung) indicates a type of lung cancer with a tumor size greater than 3 cm and up to 5 cm, potentially affecting the main bronchus or visceral pleura, but without any invasion into the chest wall or diaphragm.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2a (lung)",
    "definition": "pT2a (lung) denotes a category of lung cancer where the tumor measures over 3 cm and up to 5 cm, possibly involving the main bronchus or visceral pleura,",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2a (lung)",
    "definition": "pT2a (lung) is a designation for lung cancer characterized by a tumor size exceeding 3 cm but not surpassing 5 cm, which may affect the main bronchus or visceral pleura, while remaining free from invasion into the chest wall or diaphragm.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2a (lung)",
    "definition": "pT2a (lung) refers to a classification of lung cancer where the tumor is larger than 3 cm but not larger than 5 cm and may involve the main bronchus or the visceral pleura, without any invasion into the chest wall or diaphragm.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT2c (ovary)",
    "definition": "pT2c (ovary) denotes a staging classification that signifies the presence of ovarian cancer in both ovaries and potentially in adjacent pelvic tissues, while excluding any spread to distant locations.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2c (ovary)",
    "definition": "pT2c (ovary) describes a category that shows ovarian cancer has disseminated to both ovaries and possibly to nearby pelvic tissues, without involvement of distant sites.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2c (ovary)",
    "definition": "pT2c (ovary) is a staging term that indicates ovarian cancer has affected both ovaries and may have extended to surrounding pelvic structures, but has not metastasized to distant areas.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2c (ovary)",
    "definition": "pT2c (ovary) refers to a classification indicating that ovarian cancer has spread to both ovaries and possibly to nearby pelvic tissues, but not to distant sites.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "Stage IVA (FIGO)",
    "definition": "Stage IVA (FIGO) denotes a cancer classification indicating that the malignancy has extended to adjacent organs or tissues, including the bladder or rectum, while remaining localized from distant locations.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IVA (FIGO)",
    "definition": "Stage IVA (FIGO) describes a category of cancer where the tumor has metastasized to surrounding organs or tissues, such as the bladder or rectum, but has not reached distant sites.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IVA (FIGO)",
    "definition": "Stage IVA (FIGO) is a cancer classification that signifies the disease has infiltrated neighboring organs or tissues, like the bladder or rectum, without metastasizing to remote areas.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IVA (FIGO)",
    "definition": "Stage IVA (FIGO) refers to a classification of cancer in which the disease has spread to nearby organs or tissues, such as the bladder or rectum, but not to distant sites.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "micrometer",
    "definition": "A micrometer may refer to either a device designed for precise measurements utilizing a calibrated screw or a micrometre, which is equivalent to one millionth of a meter.",
    "type": "length unit"
  },
  {
    "term": "micrometer",
    "definition": "Micrometer can mean:Micrometer (device), used for accurate measurements by means of a calibrated screw Micrometre, a millionth of a metre",
    "type": "length unit"
  },
  {
    "term": "micrometer",
    "definition": "Micrometer can signify either a device that achieves precise measurements through a calibrated screw or a micrometre, denoting a measurement of one millionth of a meter.",
    "type": "length unit"
  },
  {
    "term": "micrometer",
    "definition": "The term micrometer can denote a measuring instrument that employs a calibrated screw for accurate readings, or it can refer to a micrometre, which represents one millionth of a meter.",
    "type": "length unit"
  },
  {
    "term": "gram per liter",
    "definition": "A gram per liter is a concentration measurement indicating the amount of a substance in grams present in one liter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "gram per liter",
    "definition": "A gram per liter is a unit of concentration that expresses the mass of a substance in grams contained in one liter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "gram per liter",
    "definition": "A gram per liter serves as a unit of concentration that quantifies the mass of a substance in grams found in a liter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "gram per liter",
    "definition": "The unit of concentration known as grams per liter reflects the mass of a substance measured in grams within one liter of a solution.",
    "type": "concentration unit"
  },
  {
    "term": "InBios",
    "definition": "InBios is a biotech firm specializing in the creation and production of diagnostic assays for infectious illnesses.",
    "type": "manufacturer"
  },
  {
    "term": "InBios",
    "definition": "InBios is a biotechnology company that develops and manufactures diagnostic tests for infectious diseases.",
    "type": "manufacturer"
  },
  {
    "term": "InBios",
    "definition": "InBios is a biotechnology enterprise focused on designing and producing diagnostic tools for infectious diseases.",
    "type": "manufacturer"
  },
  {
    "term": "InBios",
    "definition": "InBios is a company in the biotechnology sector that innovates and produces diagnostic tests aimed at identifying infectious diseases.",
    "type": "manufacturer"
  },
  {
    "term": "OWL",
    "definition": "The owl belongs to the group of predatory birds.",
    "type": "data format specification"
  },
  {
    "term": "OWL",
    "definition": "The owl is a bird of prey.",
    "type": "data format specification"
  },
  {
    "term": "OWL",
    "definition": "The owl is a raptor.",
    "type": "data format specification"
  },
  {
    "term": "OWL",
    "definition": "The owl is classified as a hunting bird.",
    "type": "data format specification"
  },
  {
    "term": "G1 (WHO)",
    "definition": "G1 (WHO) denotes the initial category in the World Health Organization's tumor classification framework, signifying that the tumor is well-differentiated and exhibits a minimal likelihood of aggressive characteristics.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G1 (WHO)",
    "definition": "G1 (WHO) is the primary level in the World Health Organization's system for classifying tumors, indicating that the tumor is well-differentiated and has a low chance of aggressive behavior.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G1 (WHO)",
    "definition": "G1 (WHO) refers to the first stage of the World Health Organization's classification system for tumors, indicating that the tumor is well-differentiated and has a low potential for aggressive behavior.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G1 (WHO)",
    "definition": "G1 (WHO) represents the first level in the World Health Organization's classification of tumors, suggesting that the tumor is well-differentiated and has a reduced risk of aggressive tendencies.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "Stage IB2 (FIGO)",
    "definition": "Stage IB2 (FIGO) denotes a category of cervical cancer characterized by an invasive tumor exceeding 2 centimeters in size, localized to the cervix, and showing no signs of metastasis to adjacent tissues or lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IB2 (FIGO)",
    "definition": "Stage IB2 (FIGO) indicates a type of cervical cancer where the tumor is invasive, larger than 2 cm, limited to the cervix, and presents no indication of dissemination to nearby tissues or lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IB2 (FIGO)",
    "definition": "Stage IB2 (FIGO) is a classification for cervical cancer in which the tumor is invasive, measures more than 2 centimeters, remains restricted to the cervix, and does not exhibit any signs of spreading to surrounding tissues or lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IB2 (FIGO)",
    "definition": "Stage IB2 (FIGO) refers to a classification of cervical cancer where the tumor is invasive, larger than 2 centimeters, and confined to the cervix, with no evidence of spread to nearby tissues or lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "pN2 (lung)",
    "definition": "pN2 (lung) denotes the categorization of regional lymph node involvement in lung cancer, signifying that the malignancy has metastasized to several lymph nodes on the same side of the thorax as the original tumor.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN2 (lung)",
    "definition": "pN2 (lung) describes the staging of regional lymph node engagement in lung cancer, indicating that the disease has disseminated to multiple lymph nodes located on the same side of the chest as the primary neoplasm.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN2 (lung)",
    "definition": "pN2 (lung) refers to the classification of regional lymph node involvement in lung cancer, indicating that cancer has spread to multiple lymph nodes on the same side of the chest as the primary tumor.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN2 (lung)",
    "definition": "pN2 (lung) represents the classification of regional lymph node involvement in lung cancer, suggesting that the tumor has extended to several lymph nodes on the same side of the chest as the primary cancer site.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "colony forming unit per volume",
    "definition": "Colony forming unit per volume is a measure of the number of viable microorganisms in a given volume of a sample, indicating their ability to grow and form colonies.",
    "type": "concentration unit"
  },
  {
    "term": "colony forming unit per volume",
    "definition": "Colony-forming units per volume quantify the count of living microorganisms within a specific volume of a sample, reflecting their potential to proliferate and develop colonies.",
    "type": "concentration unit"
  },
  {
    "term": "colony forming unit per volume",
    "definition": "The measurement of colony-forming units per unit volume assesses the quantity of viable microbes in a sample, signifying their capacity for growth and colony formation.",
    "type": "concentration unit"
  },
  {
    "term": "colony forming unit per volume",
    "definition": "The number of colony-forming units per volume serves as an indicator of the viable microorganisms present in a particular sample volume, demonstrating their ability to grow and form colonies.",
    "type": "concentration unit"
  },
  {
    "term": "Stage IIIA (AJCC 7th)",
    "definition": "Stage IIIA (AJCC 7th) denotes a cancer classification in which the tumor has metastasized to adjacent lymph nodes without affecting distant locations, signifying a more progressed local condition that might necessitate intensive therapy.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIIA (AJCC 7th)",
    "definition": "Stage IIIA (AJCC 7th) is a cancer stage indicating that the tumor has infiltrated nearby lymph nodes while remaining localized, suggesting a more severe local disease that could demand rigorous treatment.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIIA (AJCC 7th)",
    "definition": "Stage IIIA (AJCC 7th) refers to a classification of cancer where the tumor has spread to nearby lymph nodes but not to distant sites, indicating a more advanced local disease that may require aggressive treatment.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIIA (AJCC 7th)",
    "definition": "The classification of Stage IIIA (AJCC 7th) indicates that the cancer has spread to surrounding lymph nodes but has not reached distant areas, reflecting a more advanced local disease state that may require more aggressive intervention.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "pT3c (kidney)",
    "definition": "pT3c (kidney) denotes a stage of kidney cancer characterized by the tumor's invasion into the renal vein or its branches, without any metastasis to distant locations.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3c (kidney)",
    "definition": "pT3c (kidney) indicates a type of kidney cancer in which the tumor has penetrated the renal vein or its branches, yet has not disseminated to remote areas.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3c (kidney)",
    "definition": "pT3c (kidney) refers to a classification of kidney cancer where the tumor has invaded the renal vein or its branches but has not spread to distant sites.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3c (kidney)",
    "definition": "pT3c (kidney) signifies a classification of kidney cancer where the tumor has extended into the renal vein or its branches, but has not metastasized to other parts of the body.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "liter",
    "definition": "A liter is a unit of measurement in the metric system for volume, corresponding to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), where a cubic decimeter is defined as a volume of 10 cm × 10 cm × 10 cm, equating to one-thousandth of",
    "type": "volume unit"
  },
  {
    "term": "liter",
    "definition": "The liter, a metric volume measurement, is equivalent to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), with a cubic decimeter representing a space of 10 cm × 10 cm × 10 cm, making it one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "liter",
    "definition": "The litre or liter is a metric unit of volume. It is equal to 1 cubic decimetre (dm3), 1000 cubic centimetres (cm3) or 0.001 cubic metres (m3). A cubic decimetre occupies a volume of 10 cm × 10 cm × 10 cm and is thus equal to one-thousandth of a cubic metre.",
    "type": "volume unit"
  },
  {
    "term": "cubic decimeter",
    "definition": "The liter, a metric volume measurement, is equivalent to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³); a cubic decimeter corresponds to a space of 10 cm x 10 cm x 10 cm, making it one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "cubic decimeter",
    "definition": "The litre or liter is a metric unit of volume. It is equal to 1 cubic decimetre (dm3), 1000 cubic centimetres (cm3) or 0.001 cubic metres (m3). A cubic decimetre occupies a volume of 10 cm × 10 cm × 10 cm and is thus equal to one-thousandth of a cubic metre.",
    "type": "volume unit"
  },
  {
    "term": "cubic decimeter",
    "definition": "The litre, which is a unit of volume in the metric system, corresponds to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), with a cubic decimeter defined as a volume of 10 cm x 10 cm x 10 cm, thus representing one-thousandth of a cubic",
    "type": "volume unit"
  },
  {
    "term": "week",
    "definition": "A week consists of seven days and serves as a common time measurement for short durations globally, typically representing both workdays and days of rest or worship, and is aligned with annual calendars, totaling slightly more than 52 weeks annually; the term \"week\" can also denote specific segments like the workweek and the weekend.",
    "type": "time unit"
  },
  {
    "term": "week",
    "definition": "A week is a unit of time equal to seven days. It is the standard time period used for short cycles of days in most parts of the world. The days are often used to indicate common work days and rest days, as well as days of worship. Weeks are often mapped against yearly calendars. There are just over 52 weeks in a year. The term \"week\" may also be used to refer to a sub-section of the week, such as the workweek and weekend.",
    "type": "time unit"
  },
  {
    "term": "week",
    "definition": "A week, defined as a seven-day period, is a widely recognized time frame for brief cycles across the globe, often signifying both labor and leisure days, as well as religious observances, and is integrated into yearly calendars, amounting to just over 52 weeks per year, with \"week\" also referring to divisions such as the workweek and weekend.",
    "type": "time unit"
  },
  {
    "term": "week",
    "definition": "Spanning seven days, a week is a",
    "type": "time unit"
  },
  {
    "term": "Bruker Daltonics",
    "definition": "An American company located in Billerica, Massachusetts, Bruker Corporation is publicly traded and focuses on producing scientific instruments",
    "type": "manufacturer"
  },
  {
    "term": "Bruker Daltonics",
    "definition": "Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies (BEST) divisions.",
    "type": "manufacturer"
  },
  {
    "term": "Bruker Daltonics",
    "definition": "Bruker Corporation, based in Billerica, Massachusetts, is a publicly traded American company that produces scientific instruments for research in molecular and materials science, along with industrial and applied analysis, and oversees the Bruker Scientific Instruments and Bruker Energy & Supercon Technologies (BEST) divisions.",
    "type": "manufacturer"
  },
  {
    "term": "Bruker Daltonics",
    "definition": "Headquartered in Billerica, Massachusetts, Bruker Corporation is a publicly listed American firm that specializes in manufacturing scientific instruments for molecular and materials research, as well as for industrial and applied analytics, and includes the Bruker Scientific Instruments and Bruker Energy & Supercon Technologies (BEST) divisions.",
    "type": "manufacturer"
  },
  {
    "term": "to be replaced with external ontology term",
    "definition": "\"'To be substituted with an external ontology term' signifies the act of replacing a specific term with a standardized term from an external classification framework to maintain uniformity and clarity in communication.\"",
    "type": "curation status specification"
  },
  {
    "term": "to be replaced with external ontology term",
    "definition": "\"Replacing a specific term with a standardized term from an external classification system to promote uniformity and clarity in communication is referred to as 'to be substituted with an external ontology term.' \"",
    "type": "curation status specification"
  },
  {
    "term": "to be replaced with external ontology term",
    "definition": "\"The phrase 'to be substituted with an external ontology term' indicates the process of exchanging a particular term for a standardized one from an external classification system to enhance consistency and clarity in communication.\"",
    "type": "curation status specification"
  },
  {
    "term": "to be replaced with external ontology term",
    "definition": "\"To be replaced with external ontology term\" means substituting a specific term with a standardized term from an external classification system to ensure consistency and clarity in communication.",
    "type": "curation status specification"
  },
  {
    "term": "G1: Well differentiated",
    "definition": "G1: A tumor classified as well-differentiated exhibits structural and functional similarities to normal tissue, which implies a lower malignancy level and an improved prognosis.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "G1: Well differentiated",
    "definition": "G1: A well-differentiated tumor is one that closely mimics the structure and function of normal tissue, suggesting a reduced level of malignancy and a more favorable outlook.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "G1: Well differentiated",
    "definition": "G1: Well differentiated refers to a tumor that closely resembles normal tissue in structure and function, indicating a lower degree of malignancy and a better prognosis.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "G1: Well differentiated",
    "definition": "G1: Well-differentiated tumors are those that bear a strong resemblance to normal tissue in both structure and function, indicating a lower malignancy and a more optimistic prognosis.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "pT3 (colon)",
    "definition": "pT3 (colon) denotes a category that signifies a colon tumor has penetrated through the muscularis propria into the subserosa or adjacent tissues, yet has not metastasized to distant locations or lymph nodes.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT3 (colon)",
    "definition": "pT3 (colon) describes a stage where a colon tumor has breached the muscularis propria into the subserosa or local tissues, without having spread to lymph nodes or distant areas.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT3 (colon)",
    "definition": "pT3 (colon) is a classification that indicates a colon tumor has extended through the muscularis propria into the subserosa or surrounding tissues, but has not disseminated to distant sites or lymph nodes.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT3 (colon)",
    "definition": "pT3 (colon) refers to a classification indicating that a colon tumor has invaded through the muscularis propria into the subserosa or into nearby tissues but has not spread to distant sites or lymph nodes.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN0 (ovary)",
    "definition": "pN0 (ovary) denotes that there is no evidence of regional lymph node involvement in ovarian cancer, suggesting that the malignancy has not extended to nearby lymph nodes.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pN0 (ovary)",
    "definition": "pN0 (ovary) indicates that there is no regional lymph node involvement in ovarian cancer, meaning that cancer has not spread to nearby lymph nodes.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pN0 (ovary)",
    "definition": "pN0 (ovary) reflects the lack of regional lymph node involvement in ovarian cancer, implying that the cancer has not infiltrated surrounding lymph nodes.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pN0 (ovary)",
    "definition": "pN0 (ovary) signifies the absence of regional lymph node involvement in ovarian cancer, indicating that the disease has not metastasized to adjacent lymph nodes.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "GenePattern PCA",
    "definition": "GenePattern PCA functions as a computational tool that carries out principal component analysis to diminish the dimensionality of large biological datasets, thereby assisting in uncovering patterns and associations in the data.",
    "type": "principal components analysis dimensionality reduction"
  },
  {
    "term": "GenePattern PCA",
    "definition": "GenePattern PCA is a computational tool that performs principal component analysis to reduce the dimensionality of large biological datasets, helping to identify patterns and relationships in the data.",
    "type": "principal components analysis dimensionality reduction"
  },
  {
    "term": "GenePattern PCA",
    "definition": "GenePattern PCA is a software application designed to conduct principal component analysis, which decreases the dimensionality of extensive biological datasets, aiding in the discovery of patterns and connections within the data.",
    "type": "principal components analysis dimensionality reduction"
  },
  {
    "term": "GenePattern PCA",
    "definition": "GenePattern PCA serves as a computational resource for executing principal component analysis, effectively lowering the dimensionality of substantial biological datasets and facilitating the recognition of patterns and relationships in the information.",
    "type": "principal components analysis dimensionality reduction"
  },
  {
    "term": "FCS",
    "definition": "FCS could denote:",
    "type": "data format specification"
  },
  {
    "term": "FCS",
    "definition": "FCS may refer to:",
    "type": "data format specification"
  },
  {
    "term": "FCS",
    "definition": "FCS may stand for:",
    "type": "data format specification"
  },
  {
    "term": "FCS",
    "definition": "FCS might signify:",
    "type": "data format specification"
  },
  {
    "term": "Stage IVA (AJCC 7th)",
    "definition": "Stage IVA (AJCC 7th) denotes a cancer classification characterized by the spread of the disease to adjacent lymph nodes and/or surrounding tissues, without involvement of distant organs, signifying a more advanced local development.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IVA (AJCC 7th)",
    "definition": "Stage IVA (AJCC 7th) describes a level of cancer where the malignancy has extended to nearby lymph nodes and/or adjacent tissues, but has not reached distant areas, indicating a greater degree of local advancement.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IVA (AJCC 7th)",
    "definition": "Stage IVA (AJCC 7th) is a cancer category that indicates the disease has metastasized to nearby lymph nodes and/or other local structures, yet remains absent in distant locations, reflecting a further progression of the disease locally.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IVA (AJCC 7th)",
    "definition": "Stage IVA (AJCC 7th) refers to a classification of cancer where the disease has spread to nearby lymph nodes and/or other tissues, but not to distant sites, indicating a more advanced local progression.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "pT3b (kidney)",
    "definition": "pT3b (kidney) denotes a category of kidney cancer characterized by tumor invasion into the renal vein or its branches, without any dissemination to distant locations.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3b (kidney)",
    "definition": "pT3b (kidney) indicates a classification of kidney cancer where the tumor has extended into the renal vein or its branches, while remaining localized without distant metastasis.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3b (kidney)",
    "definition": "pT3b (kidney) refers to a classification of kidney cancer where the tumor has invaded the renal vein or its branches but has not spread to distant sites.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT3b (kidney)",
    "definition": "pT3b (kidney) signifies a stage of kidney cancer in which the tumor has penetrated the renal vein or its branches, yet has not metastasized to other areas.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "count per nanomolar",
    "definition": "Count per nanomolar is a measurement that quantifies the number of molecules or particles present in a solution for every nanomole of substance, indicating concentration in terms of particle count.",
    "type": "rate unit"
  },
  {
    "term": "count per nanomolar",
    "definition": "Count per nanomolar serves as a measurement that determines the number of molecules or particles in a solution for each nanomole of a substance, providing a way to express concentration through particle count.",
    "type": "rate unit"
  },
  {
    "term": "count per nanomolar",
    "definition": "The count per nanomolar is a metric that assesses the quantity of molecules or particles in a solution for each nanomole of substance, reflecting concentration based on particle number.",
    "type": "rate unit"
  },
  {
    "term": "count per nanomolar",
    "definition": "The measurement of count per nanomolar quantifies how many molecules or particles exist in a solution per nanomole of substance, thereby indicating concentration in terms of the number of particles.",
    "type": "rate unit"
  },
  {
    "term": "Affymetrix",
    "definition": "Affymetrix has been rebranded as Applied Biosystems, a line of DNA microarray products marketed by Thermo Fisher Scientific, which traces its roots to an American biotech R&D and manufacturing firm of the same name.",
    "type": "manufacturer"
  },
  {
    "term": "Affymetrix",
    "definition": "Affymetrix is now Applied Biosystems, a brand of DNA microarray products sold by Thermo Fisher Scientific that originated with an American biotechnology research and development and manufacturing company of the same name. The Santa Clara, California-based Affymetrix, Inc. now a part of Thermo Fisher Scientific was co-founded by Alex Zaffaroni and Stephen Fodor. Stephen Fodor and his group, based on their earlier development of methods to fabricate DNA microarrays using semiconductor manufacturing techniques.",
    "type": "manufacturer"
  },
  {
    "term": "Affymetrix",
    "definition": "Once known as Affymetrix, the brand has transitioned to Applied Biosystems, a segment of Thermo Fisher Scientific that specializes in DNA microarray products, stemming from a biotechnology company established by Alex Zaffar",
    "type": "manufacturer"
  },
  {
    "term": "Affymetrix",
    "definition": "The company formerly known as Affymetrix is now Applied Biosystems, a division of Thermo Fisher Scientific that offers DNA microarray products, and it originated from a biotechnology research and development firm co-founded by Alex Zaffaroni and Stephen Fodor in Santa Clara, California.",
    "type": "manufacturer"
  },
  {
    "term": "GenePattern module HierarchicalClusteringViewer",
    "definition": "HierarchicalClusteringViewer, a module within GenePattern, functions as a tool for visualizing hierarchical clustering results by showcasing data in a dendrogram format, thereby allowing users to analyze the relationships between samples based on their gene expression data.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module HierarchicalClusteringViewer",
    "definition": "The GenePattern module HierarchicalClusteringViewer is a tool that visualizes hierarchical clustering results by displaying data in a dendrogram format, allowing users to explore relationships between samples based on their gene expression profiles.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module HierarchicalClusteringViewer",
    "definition": "The GenePattern module known as HierarchicalClusteringViewer is designed to visualize results of hierarchical clustering by representing data in a dendrogram structure, facilitating users in examining the relationships between samples through their gene expression profiles.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module HierarchicalClusteringViewer",
    "definition": "The HierarchicalClusteringViewer module in GenePattern serves as a visualization tool for hierarchical clustering outcomes, presenting data in a dendrogram layout, which enables users to investigate the connections among samples according to their gene expression profiles.",
    "type": "GenePattern software"
  },
  {
    "term": "Stage 2 (FIGO)",
    "definition": "Stage 2 (FIGO) designates a category of gynecological malignancies, especially cervical cancer, signifying that the neoplasm has metastasized beyond the cervix into the upper two-thirds of the vagina or adjacent tissues, yet has not reached the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2 (FIGO)",
    "definition": "Stage 2 (FIGO) is a classification for gynecological cancers, notably cervical cancer, which indicates that the tumor has invaded beyond the cervix into the upper two-thirds of the vagina or nearby tissues without involving the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2 (FIGO)",
    "definition": "Stage 2 (FIGO) pertains to the categorization of gynecological tumors, particularly cervical cancer, denoting that the cancer has progressed beyond the cervix to the upper two-thirds of the vagina or",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2 (FIGO)",
    "definition": "Stage 2 (FIGO) refers to a classification of gynecological cancers, particularly cervical cancer, indicating that the tumor has spread beyond the cervix to the upper two-thirds of the vagina or the surrounding tissues but has not extended to the pelvic wall.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "minute",
    "definition": "A minute is a time measurement equivalent to 60 seconds; while it is not part of the International System of Units (SI), it is recognized for use alongside SI, with the abbreviation \"min\" and the informal prime symbol ′ occasionally representing minutes.",
    "type": "time unit"
  },
  {
    "term": "minute",
    "definition": "A minute is a unit of time defined as equal to 60 seconds. It is not a unit in the International System of Units (SI), but is accepted for use with SI. The SI symbol for minutes is min. The prime symbol ′ is also sometimes used informally to denote minutes.",
    "type": "time unit"
  },
  {
    "term": "minute",
    "definition": "A minute, which consists of 60 seconds, serves as a time unit that is not officially recognized in the International System of Units (SI) but is permitted for use with SI, commonly abbreviated as \"min,\" and sometimes informally indicated by the prime symbol ′.",
    "type": "time unit"
  },
  {
    "term": "minute",
    "definition": "Defined as 60 seconds, a minute is a temporal unit that, although not an official part of the International System of Units (SI), is accepted for use in conjunction with SI, with \"min",
    "type": "time unit"
  },
  {
    "term": "NanoString Technologies",
    "definition": "NanoString Technologies, Inc. is a biotech firm dedicated to research in discovery and translation.",
    "type": "manufacturer"
  },
  {
    "term": "NanoString Technologies",
    "definition": "NanoString Technologies, Inc. is a biotechnology company focused on discovery and translational research.",
    "type": "manufacturer"
  },
  {
    "term": "NanoString Technologies",
    "definition": "NanoString Technologies, Inc. is a company in the biotechnology sector that specializes in discovery and translational research.",
    "type": "manufacturer"
  },
  {
    "term": "NanoString Technologies",
    "definition": "NanoString Technologies, Inc. operates as a biotechnology enterprise concentrating on research for discovery and its translation.",
    "type": "manufacturer"
  },
  {
    "term": "second",
    "definition": "The second is a temporal unit created by segmenting a day into 24 hours, each hour into 60 minutes, and each minute into 60 seconds. According to the International System of",
    "type": "time unit"
  },
  {
    "term": "second",
    "definition": "The second is a time measurement established by dividing a day into 24 hours, which are further split into 60 minutes and subsequently into 60 seconds each. The official definition in the International System of Units (SI) is more exact: the second is defined based on the fixed numerical value of the caesium frequency, ΔνCs, representing the unperturbed ground-state hyperfine transition frequency of the caesium 133 atom, set at 9192631770 when measured in hertz (Hz), equivalent to s−1.",
    "type": "time unit"
  },
  {
    "term": "second",
    "definition": "The second is a unit of time derived from the division of the day first into 24 hours, then to 60 minutes, and finally to 60 seconds each. The current and formal definition in the International System of Units (SI) is more precise:The second [...] is defined by taking the fixed numerical value of the caesium frequency, ΔνCs, the unperturbed ground-state hyperfine transition frequency of the caesium 133 atom, to be 9192631770 when expressed in the unit Hz, which is equal to s−1.",
    "type": "time unit"
  },
  {
    "term": "mass volume percentage",
    "definition": "Mass volume percentage is a concentration indicator that quantifies the grams of solute found in 100 milliliters of a solution.",
    "type": "concentration unit"
  },
  {
    "term": "mass volume percentage",
    "definition": "Mass volume percentage is a concentration measurement that expresses the mass of a solute in grams per 100 milliliters of solution.",
    "type": "concentration unit"
  },
  {
    "term": "mass volume percentage",
    "definition": "Mass volume percentage refers to a concentration metric that indicates the grams of solute present in 100 milliliters of solution.",
    "type": "concentration unit"
  },
  {
    "term": "mass volume percentage",
    "definition": "The mass volume percentage is a way to quantify concentration, representing the grams of solute contained in every 100 milliliters of the solution.",
    "type": "concentration unit"
  },
  {
    "term": "Transformation-ML",
    "definition": "Transformation-ML involves employing machine learning methods to examine and interpret biological datasets, facilitating the discovery of patterns and insights that can enhance medical research and clinical applications.",
    "type": "data format specification"
  },
  {
    "term": "Transformation-ML",
    "definition": "Transformation-ML is the utilization of machine learning strategies to analyze and interpret biological data, which aids in uncovering patterns and insights beneficial for medical research and clinical practices.",
    "type": "data format specification"
  },
  {
    "term": "Transformation-ML",
    "definition": "Transformation-ML refers to the application of machine learning techniques to analyze and interpret biological data, enabling the identification of patterns and insights that can inform medical research and clinical practices.",
    "type": "data format specification"
  },
  {
    "term": "Transformation-ML",
    "definition": "Transformation-ML signifies the use of machine learning approaches to assess and decode biological information, allowing for the recognition of patterns and insights that can guide medical research and clinical practices.",
    "type": "data format specification"
  },
  {
    "term": "Stage 2B (FIGO)",
    "definition": "Stage 2B (FIGO) describes a category of cervical cancer in which the malignancy has extended to the tissues adjacent to the cervix, yet has not invaded the pelvic wall or the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2B (FIGO)",
    "definition": "Stage 2B (FIGO) indicates a type of cervical cancer characterized by the tumor's infiltration into the surrounding cervical tissues without reaching the pelvic wall or the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2B (FIGO)",
    "definition": "Stage 2B (FIGO) is a designation for cervical cancer where the tumor has infiltrated the tissues around the cervix but has not progressed to the pelvic wall or the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 2B (FIGO)",
    "definition": "Stage 2B (FIGO) refers to a classification of cervical cancer where the tumor has spread to the tissues surrounding the cervix but not to the pelvic wall or lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage I (AJCC 7th)",
    "definition": "Stage I (AJCC 7th) denotes an initial phase of cancer characterized by a tumor that is confined to its original location without involvement of adjacent lymph nodes or metastasis to distant areas.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage I (AJCC 7th)",
    "definition": "Stage I (AJCC 7th) indicates an early cancer stage in which the tumor remains localized and has not extended to surrounding lymph nodes or other distant locations.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage I (AJCC 7th)",
    "definition": "Stage I (AJCC 7th) refers to an early stage of cancer where the tumor is localized and has not spread to nearby lymph nodes or distant sites.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage I (AJCC 7th)",
    "definition": "Stage I (AJCC 7th) signifies a preliminary stage of cancer where the tumor is restricted to its site of origin and has not disseminated to nearby lymph nodes or remote regions.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "requires discussion",
    "definition": "\"Requires discussion\" denotes a matter or theme that calls for further engagement or examination to illuminate, resolve, or appreciate its nuances.",
    "type": "curation status specification"
  },
  {
    "term": "requires discussion",
    "definition": "\"Requires discussion\" indicates a scenario or subject that necessitates additional dialogue or contemplation to elucidate, address, or grasp its intricacies.",
    "type": "curation status specification"
  },
  {
    "term": "requires discussion",
    "definition": "\"Requires discussion\" refers to a situation or topic that needs further conversation or deliberation to clarify, resolve, or understand its complexities.",
    "type": "curation status specification"
  },
  {
    "term": "requires discussion",
    "definition": "The term \"requires discussion\" signifies a condition or issue that demands more discourse or consideration to clarify, settle, or comprehend its complexities.",
    "type": "curation status specification"
  },
  {
    "term": "universal",
    "definition": "\"The adjective that pertains to the universe is universal.\"",
    "type": "denotator type"
  },
  {
    "term": "universal",
    "definition": "\"The word universal serves as the descriptor for the universe.\"",
    "type": "denotator type"
  },
  {
    "term": "universal",
    "definition": "\"Universal is the term used to describe something related to the universe.\"",
    "type": "denotator type"
  },
  {
    "term": "universal",
    "definition": "Universal is the adjective for universe.",
    "type": "denotator type"
  },
  {
    "term": "G2 (WHO)",
    "definition": "G2 (WHO) classifies a tumor as moderately differentiated, indicating a moderate level of deviation in the cancer cells in contrast to well-differentiated (G1) and poorly differentiated (G3) tumors.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G2 (WHO)",
    "definition": "G2 (WHO) denotes a tumor classification that is moderately differentiated, signifying a middle degree of atypicality in the cancer cells relative to well-differentiated (G1) and poorly differentiated (G3) tumors.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G2 (WHO)",
    "definition": "G2 (WHO) identifies a tumor type that is moderately differentiated, reflecting an intermediate degree of cellular abnormality when compared to well-differentiated (G1) and poorly differentiated (G3) tumors.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G2 (WHO)",
    "definition": "G2 (WHO) refers to a classification of a tumor that is moderately differentiated, indicating an intermediate level of abnormality in the cancer cells compared to well-differentiated (G1) and poorly differentiated (G3) tumors.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "term split",
    "definition": "A term split describes the process of breaking down a single medical term into multiple distinct terms to enhance clarity or precision in communication.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "term split",
    "definition": "A term split is the act of dividing one medical term into two or more separate terms to better articulate its meaning or increase specificity in communication.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "term split",
    "definition": "A term split refers to the division of a single medical term into two or more distinct terms to clarify meaning or improve specificity in communication.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "term split",
    "definition": "The concept of a term split involves separating a single medical term into several distinct terms to provide clearer meaning or greater specificity in communication.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "pM1 (lung)",
    "definition": "pM1 (lung) denotes the existence of lung metastases arising from a primary tumor, reflecting an advanced stage of cancer dissemination beyond its original site.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1 (lung)",
    "definition": "pM1 (lung) indicates the presence of metastatic cancer in the lungs that has spread from a primary tumor, highlighting an advanced level of cancer progression beyond the original tumor site.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1 (lung)",
    "definition": "pM1 (lung) refers to the presence of distant metastases in the lungs from a primary tumor, indicating advanced cancer spread beyond the original site.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1 (lung)",
    "definition": "pM1 (lung) signifies the occurrence of distant lung metastases originating from a primary tumor, suggesting that the cancer has progressed significantly beyond its initial location.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT0 (kidney)",
    "definition": "pT0 (kidney) denotes the lack of observable primary tumor in the kidney, indicating that there is no sign of cancer present in that organ.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT0 (kidney)",
    "definition": "pT0 (kidney) indicates the absence of detectable primary tumor in the kidney, suggesting that there is no evidence of cancer in that organ.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT0 (kidney)",
    "definition": "pT0 (kidney) reflects the nonexistence of a detectable primary tumor in the kidney, suggesting that there is no proof of cancer within that organ.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT0 (kidney)",
    "definition": "pT0 (kidney) signifies that no primary tumor can be identified in the kidney, implying that there is no indication of cancer in that organ.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "placeholder removed",
    "definition": "\"Placeholder removed\" denotes the act of discarding a provisional or replacement component that was utilized to occupy a position or signify something until the definitive item or data is obtained.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "placeholder removed",
    "definition": "\"Placeholder removed\" indicates the process of discarding a temporary or alternative element that served to fill a gap or represent something until the final product or details are ready.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "placeholder removed",
    "definition": "\"Placeholder removed\" refers to the process of eliminating a temporary or substitute element that was used to fill a space or represent something until the final item or information is available.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "placeholder removed",
    "definition": "The term \"Placeholder removed\" signifies the removal of a temporary or surrogate element that was employed to occupy a space or indicate something until the ultimate item or information is accessible.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "Thermo Fisher Scientific",
    "definition": "Based in Waltham, Massachusetts, Thermo Fisher Scientific Inc. is a leading American firm in life sciences and clinical",
    "type": "organization"
  },
  {
    "term": "Thermo Fisher Scientific",
    "definition": "Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).",
    "type": "organization"
  },
  {
    "term": "Thermo Fisher Scientific",
    "definition": "Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, is a prominent American company specializing in life sciences and clinical research, serving as a worldwide provider of analytical tools, clinical development services, specialty diagnostics, and offerings in the laboratory, pharmaceutical, and biotechnology sectors, having been established in 2006 through the merger of Thermo Electron and Fisher Scientific and expanded through acquisitions such as Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).",
    "type": "organization"
  },
  {
    "term": "Agilent",
    "definition": "Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics",
    "type": "manufacturer"
  },
  {
    "term": "Agilent",
    "definition": "Agilent Technologies, Inc., an American multinational corporation based in Santa Clara, California, offers laboratory instruments, software, services, and consumables, having been founded in 1999 as a spin-off of Hewlett-Packard, with its initial public offering being the largest in Silicon Valley's history at that time, and from 1999 to 2014, it manufactured optics, semiconductors, electronic design automation software, and testing equipment for electronics.",
    "type": "manufacturer"
  },
  {
    "term": "Agilent",
    "definition": "Headquartered in Santa Clara, California, Agilent Technologies, Inc. is a global American firm that specializes in providing laboratory instruments, software, services, and consumables, having originated in 1999 as a spin-off from Hewlett-Packard, with its IPO marking the largest in Silicon",
    "type": "manufacturer"
  },
  {
    "term": "Agilent",
    "definition": "That division was restructured into Keysight, and the company has since diversified into the pharmaceutical, diagnostics and clinical, along with academic and governmental research fields.",
    "type": "manufacturer"
  },
  {
    "term": "Agilent",
    "definition": "The division was established as Keysight, which has subsequently broadened its reach into the pharmaceutical, diagnostics, clinical, and academic and governmental research markets.",
    "type": "manufacturer"
  },
  {
    "term": "Agilent",
    "definition": "The division was separated to create Keysight, which has since grown its presence in the pharmaceutical, diagnostics and clinical, as well as academic and governmental research sectors.",
    "type": "manufacturer"
  },
  {
    "term": "Agilent",
    "definition": "that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.",
    "type": "manufacturer"
  },
  {
    "term": "Stage IVB (AJCC 7th)",
    "definition": "Stage IVB (AJCC 7th) denotes advanced cancer that has metastasized to remote lymph nodes or various organs, signifying a more critical advancement of the illness.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IVB (AJCC 7th)",
    "definition": "Stage IVB (AJCC 7th) describes advanced cancer that has spread to far-off lymph nodes or other tissues, suggesting a more severe stage of the disease.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IVB (AJCC 7th)",
    "definition": "Stage IVB (AJCC 7th) indicates late-stage cancer that has disseminated to distant lymph nodes or additional organs, reflecting a more serious development of the condition.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IVB (AJCC 7th)",
    "definition": "Stage IVB (AJCC 7th) refers to advanced cancer that has spread to distant lymph nodes or other organs, indicating a more severe progression of the disease.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "G3 (Fuhrman)",
    "definition": "G3 (Fuhrman) denotes a categorization framework for kidney cancer that signifies a significant degree of nuclear variability and a heightened probability of aggressive tumor characteristics.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G3 (Fuhrman)",
    "definition": "G3 (Fuhrman) describes a classification method for renal cell carcinoma, indicating pronounced nuclear pleomorphism and a greater chance of aggressive tumor behavior.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G3 (Fuhrman)",
    "definition": "G3 (Fuhrman) is a grading system for renal cell carcinoma that reflects a substantial level of nuclear diversity and an elevated risk of aggressive tumor activity.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G3 (Fuhrman)",
    "definition": "G3 (Fuhrman) refers to a classification system for renal cell carcinoma that indicates a high level of nuclear pleomorphism and an increased likelihood of aggressive tumor behavior.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "uncurated",
    "definition": "\"Lacking curation.\"",
    "type": "curation status specification"
  },
  {
    "term": "uncurated",
    "definition": "\"Not organized.\"",
    "type": "curation status specification"
  },
  {
    "term": "uncurated",
    "definition": "\"Unedited.\"",
    "type": "curation status specification"
  },
  {
    "term": "uncurated",
    "definition": "Not curated.",
    "type": "curation status specification"
  },
  {
    "term": "Stage IB1 (FIGO)",
    "definition": "Stage IB1 (FIGO) denotes a category of cervical cancer characterized by the presence of invasive carcinoma, exhibiting a stromal invasion depth exceeding 5 mm and a maximum lateral extension of 2 cm or less, with no involvement of lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IB1 (FIGO)",
    "definition": "Stage IB1 (FIGO) is a designation for cervical cancer that involves invasive carcinoma, showing a stromal invasion depth greater than 5 mm and a horizontal spread limited to 2 cm or less, without any lymph node metastasis.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IB1 (FIGO)",
    "definition": "Stage IB1 (FIGO) refers to a classification of cervical cancer where invasive carcinoma is present, with a depth of stromal invasion greater than 5 mm and a maximum horizontal spread of 2 cm or less, without lymph node involvement.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IB1 (FIGO)",
    "definition": "The classification of Stage IB1 (FIGO) indicates cervical cancer with invasive carcinoma, where the depth of stromal invasion is more than 5 mm and the horizontal spread does not exceed 2 cm, and there is an absence of lymph",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "pN1 (ovary)",
    "definition": "The term pN1 (ovary) indicates the presence of metastatic spread to regional lymph nodes in ovarian cancer, revealing that cancer cells have infiltrated nearby lymphatic structures.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pN1 (ovary)",
    "definition": "pN1 (ovary) denotes the occurrence of metastasis in regional lymph nodes in cases of ovarian cancer, suggesting that cancerous cells have migrated to surrounding lymph nodes.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pN1 (ovary)",
    "definition": "pN1 (ovary) refers to the presence of regional lymph node metastasis in ovarian cancer, indicating that cancer cells have spread to nearby lymph nodes.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pN1 (ovary)",
    "definition": "pN1 (ovary) signifies the existence of metastatic cancer cells in the regional lymph nodes associated with ovarian cancer, demonstrating that the malignancy has extended to adjacent lymphatic tissues.",
    "type": "pathologic lymph node stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "Stage 3 (FIGO)",
    "definition": "Stage 3 (FIGO) denotes a categorization of gynecological malignancies, signifying that the cancer has disseminated from its primary location to adjacent tissues or lymph nodes, yet has not reached distant organs.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3 (FIGO)",
    "definition": "Stage 3 (FIGO) describes a type of classification for gynecological cancers, indicating that the malignancy has spread from its original location to nearby tissues or lymph nodes, without affecting distant organs.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3 (FIGO)",
    "definition": "Stage 3 (FIGO) is a classification for gynecological tumors, showing that the cancer has extended from its initial site to surrounding tissues or lymph nodes, but has not metastasized to far-off organs.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3 (FIGO)",
    "definition": "Stage 3 (FIGO) refers to a classification of gynecological cancers, indicating that the disease has spread beyond the original site to nearby tissues or lymph nodes but not to distant organs.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "cM1b (lung)",
    "definition": "cM1b (lung) denotes a category of metastatic cancer characterized by the spread of the disease to remote areas within the lungs, signifying an advanced stage and a less favorable prognosis.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1b (lung)",
    "definition": "cM1b (lung) describes a type of metastatic cancer where the malignancy has disseminated to far-off regions of the lungs, suggesting an advanced stage and an unfavorable outlook.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1b (lung)",
    "definition": "cM1b (lung) is a classification for metastatic cancer that indicates the presence of the disease in distant lung locations, reflecting an advanced stage and a worse prognosis.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM1b (lung)",
    "definition": "cM1b (lung) refers to a classification of metastatic cancer where the disease has spread to distant sites in the lungs, indicating advanced stage and a poorer prognosis.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "Compensation-ML",
    "definition": "Compensation-ML employs machine learning methods to mitigate biases within data, resulting in more accurate predictions for biomedical research and clinical use.",
    "type": "data format specification"
  },
  {
    "term": "Compensation-ML",
    "definition": "Compensation-ML is a machine learning approach that adjusts for biases in data to improve the accuracy of predictions in biomedical research and clinical applications.",
    "type": "data format specification"
  },
  {
    "term": "Compensation-ML",
    "definition": "Compensation-ML is a machine learning technique designed to correct data biases, thereby enhancing prediction accuracy in biomedical studies and clinical settings.",
    "type": "data format specification"
  },
  {
    "term": "Compensation-ML",
    "definition": "Compensation-ML utilizes a machine learning framework that addresses data biases to boost the precision of predictions in both biomedical research and clinical applications.",
    "type": "data format specification"
  },
  {
    "term": "G1 (Fuhrman)",
    "definition": "G1 (Fuhrman) is a classification system used to assess the nuclear grade of renal cell carcinoma based on the size and shape of the nuclei, with G1 indicating low-grade tumors that have well-defined, small nuclei.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G1 (Fuhrman)",
    "definition": "G1 (Fuhrman) serves as a grading system for evaluating the nuclear characteristics of renal cell carcinoma, where G1 denotes low-grade tumors characterized by small, well-defined nuclei.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G1 (Fuhrman)",
    "definition": "The G1 (Fuhrman) classification evaluates the nuclear grade of renal cell carcinoma by examining the size and morphology of nuclei, with G1 representing low-grade tumors featuring clearly defined, small nuclei.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G1 (Fuhrman)",
    "definition": "The G1 (Fuhrman) grading scheme is utilized to determine the nuclear grade of renal cell carcinoma, where a G1 classification signifies low-grade tumors that possess small, distinctly shaped nuclei.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "picomole",
    "definition": "The mole (symbol mol) is a unit of measurement, the base unit in the International System of Units (SI) for amount of substance, an SI base quantity proportional to the number of elementary entities of a substance. One mole is an aggregate of exactly 6.02214076×1023 elementary entities (approximately 602 sextillion or 602 billion times a trillion), which can be atoms, molecules, ions, ion pairs, or other particles. The number of particles in a mole is the Avogadro number (symbol N0) and the numerical value of the Avogadro constant (symbol NA) expressed in mol−1. The relationship between the mole, Avogadro number, and Avogadro constant can be expressed in the following equation:The current SI value of the mole is based on the historical definition of the mole as the amount of substance that corresponds to the number of atoms in 12 grams of 12C, which made the molar mass of a compound in grams per mole, numerically equal to the average molecular mass or formula mass of the compound expressed in daltons. With the 2019 revision of the SI, the numerical equivalence is now only approximate, but may still be assumed with high accuracy.",
    "type": "substance unit"
  },
  {
    "term": "picomole",
    "definition": "The mole (symbol mol) serves as a fundamental unit in the International System of Units (SI) for quantifying amount of substance, directly correlating to the count of elementary entities present in a given substance; specifically, one mole consists of precisely 6.02214076×10²³ entities—commonly referred to as Avogadro's number (symbol N0)—which may include atoms, molecules, ions, or other particles, and the Avogadro constant (symbol NA) is defined in mol⁻¹, with the current SI definition rooted in the historical measure corresponding to the number of atoms in 12 grams of carbon-12, linking molar mass in grams per mole to the average molecular or formula mass in daltons",
    "type": "substance unit"
  },
  {
    "term": "pT1a (ovary)",
    "definition": "The classification pT1a (ovary) pertains to ovarian cancer indicating that the tumor is limited to a single ovary and is either invisible to the naked eye or only detectable at the microscopic level.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1a (ovary)",
    "definition": "pT1a (ovary) denotes a category of ovarian cancer where the neoplasm is localized to a single ovary and is either undetectable by the naked eye or only identifiable under a microscope.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1a (ovary)",
    "definition": "pT1a (ovary) is a designation for ovarian cancer that signifies the tumor is restricted to one ovary and is either not observable or can only be detected microscopically.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1a (ovary)",
    "definition": "pT1a (ovary) refers to a classification of ovarian cancer indicating that the tumor is confined to one ovary and is either not visible or only microscopically detectable.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "RDF",
    "definition": "RDF can represent:",
    "type": "data format specification"
  },
  {
    "term": "RDF",
    "definition": "RDF could denote:",
    "type": "data format specification"
  },
  {
    "term": "RDF",
    "definition": "RDF may refer to:",
    "type": "data format specification"
  },
  {
    "term": "RDF",
    "definition": "RDF might signify:",
    "type": "data format specification"
  },
  {
    "term": "example to be eventually removed",
    "definition": "\"'Example to be eventually removed' indicates a particular sample or instance that is intended for removal or exclusion from future analyses or dialogues.\"",
    "type": "curation status specification"
  },
  {
    "term": "example to be eventually removed",
    "definition": "\"An 'Example to be eventually removed' denotes a specimen or case that is planned to be excluded or disregarded in subsequent evaluations or conversations.\"",
    "type": "curation status specification"
  },
  {
    "term": "example to be eventually removed",
    "definition": "\"Example to be eventually removed\" refers to a sample or instance that is intended to be discarded or eliminated from consideration in future analyses or discussions.",
    "type": "curation status specification"
  },
  {
    "term": "example to be eventually removed",
    "definition": "\"The term 'Example to be eventually removed' signifies a sample or instance that is meant to be thrown out or omitted from future assessments or discussions.\"",
    "type": "curation status specification"
  },
  {
    "term": "pT1a (lung)",
    "definition": "The classification pT1a (lung) describes a type of lung cancer where the tumor is confined to the lung, measuring no more than 3 centimeters in its largest dimension, and shows no invasion into surrounding areas.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1a (lung)",
    "definition": "pT1a (lung) denotes a category of lung cancer in which the tumor measures 3 centimeters or less at its largest point and remains localized within the lung, without encroaching on adjacent tissues.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1a (lung)",
    "definition": "pT1a (lung) is a designation for lung cancer characterized by a tumor size of 3 centimeters or less in its largest dimension, which is restricted to the lung and does not invade nearby structures.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1a (lung)",
    "definition": "pT1a (lung) refers to a classification of lung cancer where the tumor is 3 centimeters or smaller in greatest dimension and is confined to the lung without invasion into surrounding structures.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN0 (colon)",
    "definition": "pN0 (colon) denotes that there is no involvement of regional lymph nodes in colon cancer, which means that cancerous cells have not been found in the nearby lymphatic tissues.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN0 (colon)",
    "definition": "pN0 (colon) indicates that there is no regional lymph node involvement in colon cancer, meaning no cancer cells are detected in the nearby lymph nodes.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN0 (colon)",
    "definition": "pN0 (colon) reflects that there is no evidence of regional lymph node participation in colon cancer, implying that no malignant cells are identified in the surrounding lymph nodes.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN0 (colon)",
    "definition": "pN0 (colon) signifies the absence of regional lymph node involvement in colon cancer, indicating that no cancer cells are present in the adjacent lymph nodes.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4 (kidney)",
    "definition": "The term pT4 (kidney) describes a classification of kidney cancer where the tumor has progressed beyond the kidney and its surrounding tissues into nearby structures or organs.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT4 (kidney)",
    "definition": "pT4 (kidney) denotes a category of kidney cancer that signifies the tumor has extended beyond the kidney and adjacent tissues into nearby organs or structures.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT4 (kidney)",
    "definition": "pT4 (kidney) is a designation for kidney cancer indicating that the tumor has infiltrated beyond the kidney and its surrounding tissues into adjacent organs or structures.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT4 (kidney)",
    "definition": "pT4 (kidney) refers to a classification of kidney cancer indicating that the tumor has grown beyond the kidney and surrounding tissues into nearby structures or organs.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "microgram per liter",
    "definition": "A microgram per liter is a measurement unit that signifies the amount of a substance, equivalent to one millionth of a gram contained in one liter of fluid.",
    "type": "concentration unit"
  },
  {
    "term": "microgram per liter",
    "definition": "A microgram per liter is a unit of measurement that indicates the concentration of a substance, representing one millionth of a gram of that substance in one liter of liquid.",
    "type": "concentration unit"
  },
  {
    "term": "microgram per liter",
    "definition": "A microgram per liter serves as a metric for quantifying the concentration of a substance, denoting one millionth of a gram within a liter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "microgram per liter",
    "definition": "The unit known as microgram per liter measures the concentration of a substance, reflecting one millionth of a gram dissolved in a liter of liquid.",
    "type": "concentration unit"
  },
  {
    "term": "Helicos",
    "definition": "Helicos denotes a form of single-molecule sequencing method that allows for the real-time observation of nucleotide incorporation to directly read DNA or RNA sequences.",
    "type": "manufacturer"
  },
  {
    "term": "Helicos",
    "definition": "Helicos describes a single-molecule sequencing approach that permits the direct analysis of DNA or RNA sequences through the real-time tracking of nucleotide incorporation.",
    "type": "manufacturer"
  },
  {
    "term": "Helicos",
    "definition": "Helicos is a type of technology for single-molecule sequencing that facilitates the immediate reading of DNA or RNA sequences by monitoring nucleotide incorporation in real-time.",
    "type": "manufacturer"
  },
  {
    "term": "Helicos",
    "definition": "Helicos refers to a type of single-molecule sequencing technology that enables the direct reading of DNA or RNA sequences by observing the incorporation of nucleotides in real-time.",
    "type": "manufacturer"
  },
  {
    "term": "gram per deciliter",
    "definition": "A gram per deciliter is a metric used to quantify the amount of a substance dissolved in a liquid, representing the number of grams contained in one deciliter (0.1 liters) of solution.",
    "type": "concentration unit"
  },
  {
    "term": "gram per deciliter",
    "definition": "A gram per deciliter is a unit of measurement that expresses the concentration of a substance in a solution, indicating how many grams of that substance are present in one deciliter (one-tenth of a liter) of liquid.",
    "type": "concentration unit"
  },
  {
    "term": "gram per deciliter",
    "definition": "A gram per deciliter serves as a measurement unit that reflects the concentration of a substance in a liquid, showing the grams of that substance found in a deciliter (one-tenth of a liter) of solution.",
    "type": "concentration unit"
  },
  {
    "term": "gram per deciliter",
    "definition": "The term gram per deciliter denotes a unit of measurement for the concentration of a substance in a solution, illustrating how many grams of that substance exist in one deciliter (0.1 liters) of liquid.",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "As an illustration, the hydronium ion concentration [H3O+] is measured at 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "For instance, the concentration of the hydronium ion [H3O+] is 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "Molar concentration (also called amount-of-substance concentration or molarity) is the number of moles of solute per liter of solution. Specifically, It is a measure of the concentration of a chemical species, in particular, of a solute in a solution, in terms of amount of substance per unit volume of solution. In chemistry, the most commonly used unit for molarity is the number of moles per liter, having the unit symbol mol/L or mol/dm3 (1000 mol/m3) in SI units. Molar concentration is often depicted with square brackets around the substance of interest",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "Molar concentration, often referred to as amount-of-substance concentration or molarity, quantifies the moles of solute present in one liter of solution, serving as an indicator of a solute's concentration in a given volume; it is typically expressed in moles per liter (mol/L or mol/dm³ in SI units), and is frequently represented with square brackets around the chemical species.",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "Molarity, also known as amount-of-substance concentration, defines the quantity of solute in moles per liter of solution, providing a measure of the solute's concentration relative to the solution's volume; it is conventionally expressed in the unit of moles per liter (mol/L or mol/dm³ in SI), and",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "To exemplify, the level of hydronium ions [H3O+] is recorded as 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "micromolar",
    "definition": "for example with the hydronium ion [H3O+] = 4.57 x 10-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "Stage 1C (FIGO)",
    "definition": "Stage 1C (FIGO) classifies cervical cancer as having an invasive tumor that either invades both sides of the cervix or exceeds a depth of 5 mm, with no",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 1C (FIGO)",
    "definition": "Stage 1C (FIGO) denotes a categorization of cervical cancer characterized by an invasive tumor that has extended to both sides of the cervix or penetrated more than 5 mm deep, without any indication of metastasis to adjacent lymph nodes or distant locations.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 1C (FIGO)",
    "definition": "Stage 1C (FIGO) is a classification for cervical cancer indicating that the tumor is invasive, has affected both sides of the cervix, or has an invasion depth exceeding 5 mm, while showing no signs of involvement in nearby lymph nodes or distant areas.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 1C (FIGO)",
    "definition": "Stage 1C (FIGO) refers to a classification of cervical cancer where the tumor is invasive and has spread to both sides of the cervix or has a depth of invasion greater than 5 mm, with no evidence of spread to nearby lymph nodes or distant sites.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Low grade ovarian tumor",
    "definition": "A low-grade ovarian tumor is a form of cancer that develops gradually and is marked by milder characteristics and a more favorable outlook in comparison to high-grade tumors.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "Low grade ovarian tumor",
    "definition": "A low-grade ovarian tumor is a slow-growing cancer type distinguished by its less aggressive traits and a more positive prognosis when contrasted with high-grade tumors.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "Low grade ovarian tumor",
    "definition": "A low-grade ovarian tumor is a type of cancer that grows slowly and is characterized by less aggressive behavior and a better prognosis compared to high-grade tumors.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "Low grade ovarian tumor",
    "definition": "A low-grade ovarian tumor represents a cancer variant that progresses slowly and is defined by its less aggressive nature and improved prognosis relative to high-grade tumors.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "Millipore",
    "definition": "Millipore can denote: Millipore Corporation, a biosciences firm purchased by Merck Group in 2010; MilliporeSigma, the previous designation of Sigma-Aldrich; and Merck Millipore, an outdated brand name employed by Merck Group following the acquisition of Millipore.",
    "type": "manufacturer"
  },
  {
    "term": "Millipore",
    "definition": "Millipore could refer to: Millipore Corporation, a bios",
    "type": "manufacturer"
  },
  {
    "term": "Millipore",
    "definition": "Millipore may refer to:Millipore Corporation, a biosciences company acquired by Merck Group in 2010 MilliporeSigma, former name of Sigma-Aldrich Merck Millipore, deprecated brand name used by Merck Group after Millipore acquisition",
    "type": "manufacturer"
  },
  {
    "term": "Millipore",
    "definition": "The term Millipore might signify: Millipore Corporation, a biosciences entity taken over by Merck Group in 2010; MilliporeSigma, the earlier title of Sigma-Aldrich; and Merck Millipore, a now-obsolete brand name utilized by Merck Group post-Millipore acquisition.",
    "type": "manufacturer"
  },
  {
    "term": "pM1 (kidney)",
    "definition": "pM1 (kidney) denotes the existence of distant metastatic lesions in the kidney, signifying that the cancer has disseminated from its primary location to this organ.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pM1 (kidney)",
    "definition": "pM1 (kidney) indicates the occurrence of remote metastases within the kidney, suggesting that the cancer has migrated from its initial site to this organ.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pM1 (kidney)",
    "definition": "pM1 (kidney) refers to the presence of distant metastases in the kidney, indicating that cancer has spread from its original site to this organ.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pM1 (kidney)",
    "definition": "pM1 (kidney) signifies the presence of metastatic spread to the kidney, demonstrating that the cancer has extended from its original site to this organ.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "Invitrogen",
    "definition": "Invitrogen is a brand within the Thermo Fisher Scientific company, offering a range of biotechnology products that encompass subbrands for equipment and consumables related to polymerase chain reaction, reverse transcription, cloning, cell culture, stem cell generation, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA extraction, diagnostic assays, antibodies, and immunoassays.",
    "type": "manufacturer"
  },
  {
    "term": "Invitrogen",
    "definition": "Invitrogen is one of several brands under the Thermo Fisher Scientific corporation. The product line includes various subbrands of biotechnology products, such as machines and consumables for polymerase chain reaction, reverse transcription, cloning, culturing, stem cell production, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA purification, diagnostic tests, antibodies, and immunoassays.",
    "type": "manufacturer"
  },
  {
    "term": "Invitrogen",
    "definition": "Under the Thermo Fisher Scientific umbrella, Invitrogen represents one of several brands that provide a diverse array of biotechnology products, including subbrands focused on devices and consumables for applications like polymerase chain reaction, reverse transcription, cloning, cell culture, stem cell development, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA purification, diagnostic testing",
    "type": "manufacturer"
  },
  {
    "term": "BIO-RAD",
    "definition": "BIO-RAD is a biotech firm that creates and produces products and technologies aimed at life science research and clinical testing.",
    "type": "manufacturer"
  },
  {
    "term": "BIO-RAD",
    "definition": "BIO-RAD is a biotechnology company that develops and manufactures products and technologies for life science research and clinical diagnostics.",
    "type": "manufacturer"
  },
  {
    "term": "BIO-RAD",
    "definition": "BIO-RAD is a biotechnology organization focused on the development and production of tools and technologies for research in life sciences and clinical diagnostics.",
    "type": "manufacturer"
  },
  {
    "term": "BIO-RAD",
    "definition": "BIO-RAD is a company in the biotechnology sector that designs and manufactures technologies and products for research in life sciences and diagnostic applications.",
    "type": "manufacturer"
  },
  {
    "term": "G4 (Fuhrman)",
    "definition": "G4 (Fuhrman) denotes a categorization scheme for kidney cancer that signifies a significant degree of nuclear variability and a heightened likelihood of aggressive tumor characteristics.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G4 (Fuhrman)",
    "definition": "G4 (Fuhrman) describes a classification for renal cell carcinoma that indicates a pronounced level of nuclear pleomorphism and a greater risk of aggressive tumor behavior.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G4 (Fuhrman)",
    "definition": "G4 (Fuhrman) is a grading system for renal cell carcinoma that reflects a substantial presence of nuclear pleomorphism and an elevated risk of aggressive tumor behavior.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "G4 (Fuhrman)",
    "definition": "G4 (Fuhrman) refers to a classification system for renal cell carcinoma that indicates a high level of nuclear pleomorphism and an increased risk of aggressive tumor behavior.",
    "type": "histologic grade according to the Fuhrman Nuclear Grading System"
  },
  {
    "term": "pT0 (lung)",
    "definition": "pT0 (lung) denotes the lack of primary tumor tissue in the lung, indicating that no tumor is observable at that site.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT0 (lung)",
    "definition": "pT0 (lung) indicates the absence of primary tumor tissue in the lung, suggesting that no tumor is detectable at the site.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT0 (lung)",
    "definition": "pT0 (lung) reflects the non-existence of primary tumor material in the lung, suggesting that a tumor is not discernible in that area.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT0 (lung)",
    "definition": "pT0 (lung) signifies that there is no primary tumor present in the lung, implying that no tumor can be identified in that location.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "Nimblegen",
    "definition": "F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.",
    "type": "manufacturer"
  },
  {
    "term": "Nimblegen",
    "definition": "F. Hoffmann-La Roche AG, more widely referred to as Roche, is a Swiss multinational healthcare corporation that functions globally through two main sectors: Pharmaceuticals and Diagnostics. Its parent company, Roche Holding AG, is publicly traded on the SIX Swiss Exchange, with its headquarters situated in Basel. Roche ranks as the fifth-largest pharmaceutical firm worldwide by revenue and stands as the foremost supplier of cancer therapies internationally. In 2023, it was positioned 76th in the Forbes Global 2000 rankings.",
    "type": "manufacturer"
  },
  {
    "term": "Nimblegen",
    "definition": "Known as Roche, F. Hoffmann-La Roche AG is a Swiss multinational healthcare entity that operates globally across two divisions: Pharmaceuticals and Diagnostics. The holding company, Roche Holding AG, is listed on the SIX Swiss Exchange, with its main office located",
    "type": "manufacturer"
  },
  {
    "term": "pT2b (ovary)",
    "definition": "pT2b (ovary) denotes a staging category that signifies the spread of ovarian cancer to one or both fallopian tubes and/or the pelvic peritoneum, without extending past the pelvic region.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2b (ovary)",
    "definition": "pT2b (ovary) indicates a tumor classification where ovarian cancer has metastasized to one or both fallopian tubes and/or the pelvic peritoneum, but has not advanced outside the pelvis.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2b (ovary)",
    "definition": "pT2b (ovary) is a classification that indicates the presence of ovarian cancer in one or both fallopian tubes and/or the pelvic peritoneum, while remaining confined to the pelvic area.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT2b (ovary)",
    "definition": "pT2b (ovary) refers to a classification indicating that ovarian cancer has spread to one or both fallopian tubes and/or the pelvic peritoneum, but not beyond the pelvis.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "GenePattern k-nearest neighbors",
    "definition": "GenePattern k-nearest neighbors is a machine learning method used for classifying data points based on the similarity of their features to those of their nearest neighbors in a dataset.",
    "type": "k-nearest neighbors"
  },
  {
    "term": "GenePattern k-nearest neighbors",
    "definition": "GenePattern's k-nearest neighbors algorithm is a machine learning technique that classifies data points by evaluating the resemblance of their attributes to those of the closest neighbors within a dataset.",
    "type": "k-nearest neighbors"
  },
  {
    "term": "GenePattern k-nearest neighbors",
    "definition": "In GenePattern, the k-nearest neighbors technique is employed as a machine learning strategy for classifying data points by assessing the similarity of their features to those of nearby data points in a given dataset.",
    "type": "k-nearest neighbors"
  },
  {
    "term": "GenePattern k-nearest neighbors",
    "definition": "The k-nearest neighbors method in GenePattern is a machine learning approach that categorizes data points according to how similar their characteristics are to those of their nearest neighbors in the dataset.",
    "type": "k-nearest neighbors"
  },
  {
    "term": "count per nanomolar second",
    "definition": "Count per nanomolar second is a measurement of the number of events or reactions occurring per second in a solution where the concentration of a substance is one nanomolar.",
    "type": "rate unit"
  },
  {
    "term": "count per nanomolar second",
    "definition": "Count per nanomolar second refers to the rate of occurrences or reactions per second in a solution that has a concentration of one nanomolar.",
    "type": "rate unit"
  },
  {
    "term": "count per nanomolar second",
    "definition": "The count per nanomolar second quantifies the frequency of events or reactions happening each second in a solution at a concentration of one nanomolar.",
    "type": "rate unit"
  },
  {
    "term": "count per nanomolar second",
    "definition": "The measurement known as count per nanomolar second indicates how many events or reactions take place per second in a solution with a one nanomolar concentration of a substance.",
    "type": "rate unit"
  },
  {
    "term": "cM1b (colon)",
    "definition": "cM1b (colon) denotes a category of colon cancer that has spread to distant locations, particularly affecting one or more organs beyond the colon, but not including the liver and lungs.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "cM1b (colon)",
    "definition": "cM1b (colon) indicates a type of colon cancer that has disseminated to distant sites, notably impacting one or more organs outside the colon, excluding both the liver and lungs.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "cM1b (colon)",
    "definition": "cM1b (colon) is a designation for colon cancer that has metastasized to remote areas, specifically involving one or more organs outside of the colon, while excluding the liver and lungs.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "cM1b (colon)",
    "definition": "cM1b (colon) refers to a classification of colon cancer that has metastasized to distant sites, specifically to one or more organs outside the colon, excluding the liver and lungs.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "meter",
    "definition": "In the International System of Units (SI), the meter is the",
    "type": "length unit"
  },
  {
    "term": "meter",
    "definition": "The International System of Units (SI) designates the meter as its primary unit of length, which has been defined since 2019 as the distance light covers in a vacuum over a duration of 1/299,792,458 seconds, where the second is established based on the hyperfine transition frequency of cesium.",
    "type": "length unit"
  },
  {
    "term": "meter",
    "definition": "The meter serves as the fundamental unit of length in the International System of Units (SI), and as of 2019, it is defined as the distance light travels in a vacuum in a time span of 1/299,792,458 of a second, with the second being determined by the hyperfine transition frequency of cesium.",
    "type": "length unit"
  },
  {
    "term": "meter",
    "definition": "The metre is the base unit of length in the International System of Units (SI). Since 2019, the metre has been defined as the length of the path travelled by light in vacuum during a time interval of ⁠1/299792458⁠ of a second, where the second is defined by a hyperfine transition frequency of caesium.",
    "type": "length unit"
  },
  {
    "term": "High grade ovarian tumor",
    "definition": "A high-grade ovarian tumor is a form of aggressive malignancy that develops in the ovaries, identified by its poorly differentiated cellular structure and propensity for rapid growth and spread.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "High grade ovarian tumor",
    "definition": "A high-grade ovarian tumor is a type of aggressive cancer originating in the ovaries, characterized by poorly differentiated cells that tend to grow and spread rapidly.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "High grade ovarian tumor",
    "definition": "A high-grade ovarian tumor is an aggressive form of cancer that arises in the ovaries, marked by cells that are poorly differentiated and exhibit rapid growth and metastasis.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "High grade ovarian tumor",
    "definition": "A high-grade ovarian tumor represents a severe variant of cancer that originates in the ovaries, distinguished by undifferentiated cells that typically proliferate and disseminate quickly.",
    "type": "histologic grade for ovarian tumor according to a two-tier grading system"
  },
  {
    "term": "GenePattern hierarchical clustering",
    "definition": "GenePattern hierarchical clustering is a computational method used to group similar biological data points, such as gene expression profiles, into a tree-like structure based on their similarities.",
    "type": "hierarchical clustering"
  },
  {
    "term": "GenePattern hierarchical clustering",
    "definition": "GenePattern hierarchical clustering is a computational technique that organizes comparable biological data, including gene expression profiles, into a tree-like arrangement according to their similarities.",
    "type": "hierarchical clustering"
  },
  {
    "term": "GenePattern hierarchical clustering",
    "definition": "GenePattern hierarchical clustering serves as a computational approach to categorize akin biological data points, like gene expression profiles, into a dendritic structure based on their resemblances.",
    "type": "hierarchical clustering"
  },
  {
    "term": "GenePattern hierarchical clustering",
    "definition": "The hierarchical clustering method in GenePattern is a computational strategy employed to classify similar biological data sets, such as gene expression profiles, into a tree structure reflecting their similarities.",
    "type": "hierarchical clustering"
  },
  {
    "term": "Exbio Antibodies",
    "definition": "Exbio Antibodies are a collection of custom proteins formulated to uniquely interact with target antigens for purposes in research, diagnostics, and treatment.",
    "type": "manufacturer"
  },
  {
    "term": "Exbio Antibodies",
    "definition": "Exbio Antibodies are a range of specialized proteins designed to specifically bind to target antigens for use in research, diagnostics, and therapeutic applications.",
    "type": "manufacturer"
  },
  {
    "term": "Exbio Antibodies",
    "definition": "Exbio Antibodies consist of a variety of tailored proteins intended to selectively attach to specific antigens for applications in research, diagnostic testing, and therapy.",
    "type": "manufacturer"
  },
  {
    "term": "Exbio Antibodies",
    "definition": "Exbio Antibodies represent a set of engineered proteins aimed at specifically recognizing target antigens for utilization in research, diagnostic processes, and therapeutic interventions.",
    "type": "manufacturer"
  },
  {
    "term": "Stage IA2 (FIGO)",
    "definition": "Stage IA2 (FIGO) denotes a category of cervical cancer characterized by the presence of invasive cancer that invades the stroma to a depth exceeding 5 mm but not surpassing 10 mm, without any invasion into the lymphovascular spaces.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IA2 (FIGO)",
    "definition": "Stage IA2 (FIGO) is a classification for cervical cancer indicating that invasive cancer exists with stromal invasion depth between 5 mm and 10 mm, and it does not involve lymphovascular space invasion.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IA2 (FIGO)",
    "definition": "Stage IA2 (FIGO) refers to a classification of cervical cancer where invasive cancer is present, with a depth of stromal invasion greater than 5 mm and less than or equal to 10 mm, and no lymphovascular space invasion.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IA2 (FIGO)",
    "definition": "The classification of Stage IA2 (FIGO) in cervical cancer indicates the presence of invasive cancer with a stromal invasion depth greater than 5 mm and up to 10 mm, while showing no signs of lymphovascular space invasion.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "pT2a (kidney)",
    "definition": "pT2a (kidney) denotes a category of kidney cancer characterized by a tumor size exceeding 7 centimeters, yet contained within the kidney capsule.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2a (kidney)",
    "definition": "pT2a (kidney) indicates a type of kidney cancer in which the tumor measures over 7 centimeters without invading the kidney's outer capsule.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2a (kidney)",
    "definition": "pT2a (kidney) refers to a classification of kidney cancer where the tumor is larger than 7 centimeters but not extending beyond the kidney capsule.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2a (kidney)",
    "definition": "pT2a (kidney) signifies a classification of kidney cancer where the tumor exceeds 7 centimeters in size but remains within the confines of the kidney capsule.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "UO_0000033",
    "definition": "UO_0000033 denotes a category of biological activity characterized by the transport of materials through cellular membranes.",
    "type": "time unit"
  },
  {
    "term": "UO_0000033",
    "definition": "UO_0000033 refers to a type of biological process that involves the movement of substances across cell membranes.",
    "type": "time unit"
  },
  {
    "term": "UO_0000033",
    "definition": "UO_0000033 represents a kind of biological mechanism that entails the transfer of compounds through cell membranes.",
    "type": "time unit"
  },
  {
    "term": "UO_0000033",
    "definition": "UO_0000033 signifies a biological process associated with the translocation of substances across the membranes of cells.",
    "type": "time unit"
  },
  {
    "term": "GenePattern HeatMapViewer data visualization",
    "definition": "GenePattern HeatMapViewer functions as a visualization resource that converts complicated biological data into a heatmap format, helping users to quickly recognize trends and associations in gene expression or other quantitative analyses across samples.",
    "type": "clustered data visualization"
  },
  {
    "term": "GenePattern HeatMapViewer data visualization",
    "definition": "GenePattern HeatMapViewer is a software application that graphically displays intricate biological information in the form of a heatmap, enabling users to readily discern patterns and correlations in gene expression or other quantitative data among samples.",
    "type": "clustered data visualization"
  },
  {
    "term": "GenePattern HeatMapViewer data visualization",
    "definition": "GenePattern HeatMapViewer is a tool that visually represents complex biological data as a heatmap, allowing users to easily identify patterns and relationships in gene expression or other quantitative measurements across samples.",
    "type": "clustered data visualization"
  },
  {
    "term": "GenePattern HeatMapViewer data visualization",
    "definition": "The GenePattern HeatMapViewer serves as a visualization tool that transforms complex biological datasets into heatmap representations, facilitating the identification of patterns and connections in gene expression or various quantitative metrics across different samples.",
    "type": "clustered data visualization"
  },
  {
    "term": "Roche",
    "definition": "F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.",
    "type": "manufacturer"
  },
  {
    "term": "Roche",
    "definition": "F. Hoffmann-La Roche AG, often referred to as Roche, is a Swiss global healthcare corporation divided into two main sectors: Pharmaceuticals and Diagnostics, with its parent company, Roche Holding AG, traded on the SIX Swiss Exchange and headquartered in Basel; it ranks as the fifth-largest pharmaceutical firm worldwide by revenue and is the top supplier of cancer therapies globally, holding the 76th position in the 2023 Forbes Global 2000 list.",
    "type": "manufacturer"
  },
  {
    "term": "Roche",
    "definition": "Roche, a Swiss multinational healthcare firm known as F. Hoffmann-La Roche AG, operates globally through its two segments, Pharmaceuticals and Diagnostics, with its parent company, Roche Holding AG, listed on the SIX Swiss Exchange and based in Basel; it is recognized as the fifth-largest pharmaceutical company by revenue",
    "type": "manufacturer"
  },
  {
    "term": "GenePattern module KNN",
    "definition": "GenePattern's KNN module functions as a computational instrument for data classification, leveraging the k-nearest neighbors algorithm to find the nearest data points in a dataset for making predictions about new entries.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KNN",
    "definition": "The GenePattern module KNN is a computational tool used for classifying data based on the k-nearest neighbors algorithm, which identifies the closest data points in a dataset to make predictions about new samples.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KNN",
    "definition": "The KNN component of GenePattern serves as a computational tool that utilizes the k-nearest neighbors method to classify data by locating the closest points in a dataset to forecast new observations.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KNN",
    "definition": "The KNN module in GenePattern is a computational resource that employs the k-nearest neighbors algorithm to categorize data by determining the nearest data points in a dataset for predicting new samples.",
    "type": "GenePattern software"
  },
  {
    "term": "cM0 (kidney)",
    "definition": "cM0 (kidney) denotes a categorization signifying the absence of any signs of distant metastasis in the kidneys of a cancer patient.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "cM0 (kidney)",
    "definition": "cM0 (kidney) is a classification that indicates a cancer patient shows no evidence of metastatic spread to the kidneys.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "cM0 (kidney)",
    "definition": "cM0 (kidney) refers to a classification indicating that there is no evidence of distant metastasis in the kidneys for a patient with cancer.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "cM0 (kidney)",
    "definition": "cM0 (kidney) represents a classification that confirms the lack of distant metastatic evidence in the kidneys for individuals diagnosed with cancer.",
    "type": "pathologic distant metastases stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "microgram",
    "definition": "A microgram, represented by the symbol μg, is a unit of mass in the metric system that corresponds to one millionth of a gram, according to the International System of Units (SI).",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "According to the International System of Units (SI), a microgram (μg) is a metric unit of mass equivalent to one millionth of a gram.",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "In the United States and United Kingdom, mcg is the advised notation for expressing medical information, whereas μg denotes micro- with the Greek character μ (mu) as its prefix.",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "In the metric system, a microgram is defined as a mass unit that is one millionth of a gram, with the symbol μg as per the International System of Units (SI).",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "In the metric system, a microgram or microgramme is a unit of mass equal to one millionth of a gram. The unit symbol is μg according to the International System of Units (SI)",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "The suggested abbreviation for conveying medical data in the US and UK is mcg, while μg represents micro- using the Greek letter μ (mu) as its prefix.",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "When sharing medical information, the preferred symbol in both the United States and the United Kingdom is mcg, while μg utilizes the Greek letter μ (mu) to signify the micro- prefix.",
    "type": "mass unit"
  },
  {
    "term": "microgram",
    "definition": "the recommended symbol in the United States and United Kingdom when communicating medical information is mcg. In μg, the prefix symbol for micro- is the Greek letter μ (mu).",
    "type": "mass unit"
  },
  {
    "term": "pN1 (colon)",
    "definition": "pN1 (colon) denotes the pathological category signifying that cancer has metastasized to one to three nearby lymph nodes within the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN1 (colon)",
    "definition": "pN1 (colon) is a pathological designation that indicates the presence of cancer in one to three regional lymph nodes associated with the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN1 (colon)",
    "definition": "pN1 (colon) refers to the pathological classification indicating that cancer has spread to one to three regional lymph nodes in the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN1 (colon)",
    "definition": "pN1 (colon) represents a pathological classification that shows cancer has disseminated to one to three lymph nodes in the regional area of the colon.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4 (lung)",
    "definition": "pT4 (lung) denotes a lung cancer staging category that signifies the tumor's infiltration into adjacent tissues, including the chest wall, diaphragm, or mediastinum, or has led to other considerable local impacts.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT4 (lung)",
    "definition": "pT4 (lung) is a designation in the staging of lung cancer that indicates the tumor has penetrated surrounding structures like the chest wall, diaphragm, or mediastinum, or has resulted in other notable local consequences.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT4 (lung)",
    "definition": "pT4 (lung) refers to a classification in lung cancer staging indicating that the tumor has invaded nearby structures, such as the chest wall, diaphragm, or mediastinum, or has caused other significant local effects.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT4 (lung)",
    "definition": "pT4 (lung) represents a stage in lung cancer classification that shows the tumor has encroached upon nearby anatomical structures, such as the chest wall, diaphragm, or mediastinum, or has produced other significant local effects.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "Pacific Biosciences",
    "definition": "Founded in 2004, Pacific Biosciences of California, Inc. is an American biotech company specializing in the development and production of gene sequencing systems and advanced real-time biological observation tools, with its primary sequencing technologies being single-molecule real-time sequencing (SMRT) leveraging zero-mode waveguides and sequencing by binding (S",
    "type": "manufacturer"
  },
  {
    "term": "Pacific Biosciences",
    "definition": "Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.",
    "type": "manufacturer"
  },
  {
    "term": "Pacific Biosciences",
    "definition": "Pacific Biosciences of California, Inc., established in 2004, is a U.S.-based biotech firm that creates and produces gene sequencing technologies and innovative real-time biological monitoring systems, featuring two main sequencing platforms: single-molecule real-time sequencing (SMRT) utilizing zero-mode waveguides and sequencing by binding (SBB) chemistry that employs native nucleotides for seamless DNA binding and extension.",
    "type": "manufacturer"
  },
  {
    "term": "Stage IIA1 (FIGO)",
    "definition": "In the FIGO classification, Stage IIA1 indicates cervical cancer where the neoplasm has spread to the upper two-thirds of the vagina, but does not involve the pelvic wall or the parametrium.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA1 (FIGO)",
    "definition": "Stage IIA1 (FIGO) denotes a category of cervical cancer characterized by tumor infiltration into the upper two-thirds of the vagina without affecting the pelvic wall or the parametrium.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA1 (FIGO)",
    "definition": "Stage IIA1 (FIGO) is a designation for cervical cancer in which the tumor has penetrated the upper two-thirds of the vagina, yet remains confined to this area without extending to the pelvic wall or the parametrium.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA1 (FIGO)",
    "definition": "Stage IIA1 (FIGO) refers to a classification of cervical cancer where the tumor has invaded the upper two-thirds of the vagina but not the pelvic wall, with no involvement of the parametrium.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIB (AJCC 7th)",
    "definition": "Stage IIB (AJCC 7th) denotes a cancer classification characterized by the invasion of the tumor into surrounding lymph nodes without metastasizing to distant locations, signifying a progression beyond Stage IIA.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIB (AJCC 7th)",
    "definition": "Stage IIB (AJCC 7th) describes a cancer stage in which the tumor has infiltrated adjacent lymph nodes but has not metastasized to remote areas, indicating a more severe condition than Stage IIA.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIB (AJCC 7th)",
    "definition": "Stage IIB (AJCC 7th) is a cancer stage that indicates the presence of an invasive tumor that has affected nearby lymph nodes while remaining localized, representing a more advanced stage compared to Stage IIA.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIB (AJCC 7th)",
    "definition": "Stage IIB (AJCC 7th) refers to a classification of cancer where the tumor is invasive and has spread to nearby lymph nodes but not to distant sites, indicating a more advanced disease than Stage IIA.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "pTis (colon)",
    "definition": "pTis (colon) denotes a phase of colon cancer characterized by the existence of carcinoma in situ, signifying that malignant cells are located in the colon's superficial layer without penetrating surrounding tissues or metastasizing to other areas.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pTis (colon)",
    "definition": "pTis (colon) describes a classification of colon cancer in which carcinoma in situ is present, meaning that cancer cells are located in the colon's innermost layer and have not infiltrated deeper layers or disseminated to other regions.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pTis (colon)",
    "definition": "pTis (colon) indicates a specific stage of colon cancer where carcinoma in situ is detected, suggesting that cancer cells are present in the colon's surface layer without invading adjacent tissues or spreading elsewhere in the body.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pTis (colon)",
    "definition": "pTis (colon) refers to a stage of colon cancer where there is a presence of carcinoma in situ, indicating that cancerous cells are found in the innermost layer of the colon but have not invaded deeper tissues or spread to other parts of the body.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "Stage IIA2 (FIGO)",
    "definition": "Stage IIA2 (FIGO) denotes a category of cervical cancer characterized by tumor invasion into adjacent tissues, measuring over 5 mm in size, without metastasis to the pelvic wall or the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA2 (FIGO)",
    "definition": "Stage IIA2 (FIGO) is a classification for cervical cancer indicating that the tumor has penetrated nearby tissues, exceeds 5 mm in diameter, and has not extended to the pelvic wall or the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA2 (FIGO)",
    "definition": "Stage IIA2 (FIGO) refers to a classification of cervical cancer where the tumor has invaded the surrounding tissues and is larger than 5 mm but has not spread to the pelvic wall or lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA2 (FIGO)",
    "definition": "The FIGO classification of Stage IIA2 pertains to cervical cancer where the tumor has infiltrated surrounding tissues, is greater than 5 mm in size, and has not metastasized to the pelvic wall or the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA (FIGO)",
    "definition": "Stage IIA (FIGO) denotes a categorization of cervical cancer characterized by the tumor's invasion into the upper two-thirds of the vagina, while remaining confined to the pelvic region without affecting the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA (FIGO)",
    "definition": "Stage IIA (FIGO) describes a stage of cervical cancer in which the tumor has infiltrated the upper two-thirds of the vagina, yet has not metastasized to the pelvic wall or involved the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA (FIGO)",
    "definition": "Stage IIA (FIGO) is a designation for cervical cancer in which the tumor has penetrated the upper two-thirds of the vagina but has not extended to the pelvic wall or impacted the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IIA (FIGO)",
    "definition": "Stage IIA (FIGO) refers to a classification of cervical cancer where the tumor has invaded the upper two-thirds of the vagina but has not spread to the pelvic wall or involved the lower third of the vagina.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "microgram",
    "definition": "A microgram, represented by the symbol μg, is a unit of mass in the metric system that corresponds to one millionth of a gram, according to the International System of Units (SI).",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "According to the International System of Units (SI), a microgram (μg) is a metric unit of mass equivalent to one millionth of a gram.",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "In the United States and United Kingdom, mcg is the advised notation for expressing medical information, whereas μg denotes micro- with the Greek character μ (mu) as its prefix.",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "In the metric system, a microgram is defined as a mass unit that is one millionth of a gram, with the symbol μg as per the International System of Units (SI).",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "In the metric system, a microgram or microgramme is a unit of mass equal to one millionth of a gram. The unit symbol is μg according to the International System of Units (SI)",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "The suggested abbreviation for conveying medical data in the US and UK is mcg, while μg represents micro- using the Greek letter μ (mu) as its prefix.",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "When sharing medical information, the preferred symbol in both the United States and the United Kingdom is mcg, while μg utilizes the Greek letter μ (mu) to signify the micro- prefix.",
    "type": "substance unit"
  },
  {
    "term": "microgram",
    "definition": "the recommended symbol in the United States and United Kingdom when communicating medical information is mcg. In μg, the prefix symbol for micro- is the Greek letter μ (mu).",
    "type": "substance unit"
  },
  {
    "term": "micromole",
    "definition": "The mole (abbreviated as mol) serves as a fundamental unit of measurement within the International System of Units (SI) that quantifies the amount of substance, directly relating to the count of elementary entities present in that substance, with one mole defined as precisely 6.02214076×10²³ elementary entities (or about 602 sextillion), which can include atoms, molecules, ions, or other particles; this count is represented by Avogadro's number (symbol N0), and the value of the Avogadro constant (symbol NA) is given in mol−1, while the current SI definition of the mole is rooted in the historical concept of the amount of substance equivalent to the number of atoms in 12 grams of",
    "type": "substance unit"
  },
  {
    "term": "micromole",
    "definition": "The mole (symbol mol) is a unit of measurement, the base unit in the International System of Units (SI) for amount of substance, an SI base quantity proportional to the number of elementary entities of a substance. One mole is an aggregate of exactly 6.02214076×1023 elementary entities (approximately 602 sextillion or 602 billion times a trillion), which can be atoms, molecules, ions, ion pairs, or other particles. The number of particles in a mole is the Avogadro number (symbol N0) and the numerical value of the Avogadro constant (symbol NA) expressed in mol−1. The relationship between the mole, Avogadro number, and Avogadro constant can be expressed in the following equation:The current SI value of the mole is based on the historical definition of the mole as the amount of substance that corresponds to the number of atoms in 12 grams of 12C, which made the molar mass of a compound in grams per mole, numerically equal to the average molecular mass or formula mass of the compound expressed in daltons. With the 2019 revision of the SI, the numerical equivalence is now only approximate, but may still be assumed with high accuracy.",
    "type": "substance unit"
  },
  {
    "term": "pN0 (lung)",
    "definition": "pN0 (lung) denotes the absence of any detected regional lymph node involvement in a patient suffering from lung cancer.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN0 (lung)",
    "definition": "pN0 (lung) indicates that there is no regional lymph node involvement detected in a patient with lung cancer.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN0 (lung)",
    "definition": "pN0 (lung) reflects that there are no signs of regional lymph node engagement in a person with lung cancer.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN0 (lung)",
    "definition": "pN0 (lung) signifies that no regional lymph node metastasis has been observed in an individual diagnosed with lung cancer.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "Exalpha Biological",
    "definition": "Exalpha Biological is a company that specializes in the development and production of high-quality biological reagents and tools for research and diagnostic applications in the life sciences.",
    "type": "manufacturer"
  },
  {
    "term": "Exalpha Biological",
    "definition": "Exalpha Biological is a corporation dedicated to the innovation and production of top-tier biological reagents and tools intended for research and diagnostic uses in the life sciences.",
    "type": "manufacturer"
  },
  {
    "term": "Exalpha Biological",
    "definition": "Exalpha Biological is a firm focused on creating and manufacturing premium biological reagents and instruments for research and diagnostic purposes in the life sciences.",
    "type": "manufacturer"
  },
  {
    "term": "Exalpha Biological",
    "definition": "Exalpha Biological is an enterprise that concentrates on the design and fabrication of high-grade biological reagents and devices for research and diagnostic applications within the life sciences.",
    "type": "manufacturer"
  },
  {
    "term": "milliliter per liter",
    "definition": "A milliliter per liter is a measurement unit that indicates the amount of a substance in milliliters present in a single liter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "milliliter per liter",
    "definition": "A milliliter per liter is a unit of measurement that expresses the volume of a substance in milliliters contained in one liter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "milliliter per liter",
    "definition": "A milliliter per liter serves as a unit to quantify the volume of a substance in milliliters found within one liter of a solution.",
    "type": "concentration unit"
  },
  {
    "term": "milliliter per liter",
    "definition": "The unit of milliliters per liter denotes the volume of a substance measured in milliliters that is contained in one liter of a solution.",
    "type": "concentration unit"
  },
  {
    "term": "named class expression",
    "definition": "A named class expression is a particular type within biomedical taxonomy that is identified by a unique label and comprises a group of associated entities or notions.",
    "type": "denotator type"
  },
  {
    "term": "named class expression",
    "definition": "A named class expression is a specific category in biomedical classification that is defined by a unique name and encompasses a set of related entities or concepts.",
    "type": "denotator type"
  },
  {
    "term": "named class expression",
    "definition": "A named class expression refers to a distinct category within biomedical classification characterized by a specific designation and includes a collection of interconnected entities or ideas.",
    "type": "denotator type"
  },
  {
    "term": "named class expression",
    "definition": "In biomedical classification, a named class expression denotes a defined category marked by a unique title and incorporates a range of related entities or concepts.",
    "type": "denotator type"
  },
  {
    "term": "cM0 (lung)",
    "definition": "cM0 (lung) denotes a categorization signifying the absence of any signs of distant metastasis to the lungs in a cancer patient.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM0 (lung)",
    "definition": "cM0 (lung) is a classification that indicates a patient with cancer shows no signs of metastatic spread to the lungs.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM0 (lung)",
    "definition": "cM0 (lung) refers to a classification indicating that there is no evidence of distant metastasis to the lungs in a patient with cancer.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "cM0 (lung)",
    "definition": "cM0 (lung) represents a status indicating that there is no indication of metastatic disease affecting the lungs in an individual diagnosed with cancer.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "GenePattern LOOCV",
    "definition": "GenePattern LOOCV is a machine learning approach that measures the effectiveness of a predictive model by training on all samples except one and testing on the left-out sample, repeating this for each sample in the dataset.",
    "type": "leave one out cross validation method"
  },
  {
    "term": "GenePattern LOOCV",
    "definition": "GenePattern LOOCV is a machine learning method that assesses the efficacy of a predictive model by using all samples except one for training and validating it on the omitted sample, iterating this for every sample in the dataset.",
    "type": "leave one out cross validation method"
  },
  {
    "term": "GenePattern LOOCV",
    "definition": "GenePattern LOOCV is a machine learning strategy that evaluates a predictive model's performance by training on all but one sample and testing it on the sample that was excluded, continuing this for every sample within the dataset.",
    "type": "leave one out cross validation method"
  },
  {
    "term": "GenePattern LOOCV",
    "definition": "GenePattern LOOCV is a machine learning technique that evaluates the performance of a predictive model by training it on all but one sample and testing it on the excluded sample, repeating this process for each sample in the dataset.",
    "type": "leave one out cross validation method"
  },
  {
    "term": "CytoBuoy",
    "definition": "CytoBuoy is a system designed for the automated gathering and examination of cells from fluid samples, facilitating the investigation of cellular characteristics and actions.",
    "type": "manufacturer"
  },
  {
    "term": "CytoBuoy",
    "definition": "CytoBuoy is a technology used for the automated collection and analysis of cells from liquid samples, enabling the study of cellular properties and behaviors.",
    "type": "manufacturer"
  },
  {
    "term": "CytoBuoy",
    "definition": "CytoBuoy is an innovation that automates the collection and assessment of cells from liquid specimens, allowing for the exploration of cellular traits and activities.",
    "type": "manufacturer"
  },
  {
    "term": "CytoBuoy",
    "definition": "CytoBuoy represents a technological advancement for the automated retrieval and analysis of cells from liquid samples, supporting the research of cellular features and behaviors.",
    "type": "manufacturer"
  },
  {
    "term": "pTis (lung)",
    "definition": "pTis (lung) denotes a stage of lung cancer characterized by carcinoma in situ, which signifies the existence of atypical cells that have yet to infiltrate adjacent tissues.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pTis (lung)",
    "definition": "pTis (lung) describes a lung cancer stage marked by carcinoma in situ, indicating the presence of abnormal cells that have not penetrated nearby tissues.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pTis (lung)",
    "definition": "pTis (lung) refers to a stage of lung cancer where there is the presence of carcinoma in situ, indicating abnormal cells that have not invaded surrounding tissues.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pTis (lung)",
    "definition": "pTis (lung) signifies a lung cancer stage where carcinoma in situ is present, reflecting the existence of irregular cells that have not encroached upon surrounding tissues.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "left handed",
    "definition": "In human biology, handedness is an individual's preferential use of one hand, known as the dominant hand, due to and causing it to be stronger, faster or more dextrous. The other hand, comparatively often the weaker, less dextrous or simply less subjectively preferred, is called the non-dominant hand. In a study from 1975 on 7,688 children in US grades 1–6, left handers comprised 9.6% of the sample, with 10.5% of male children and 8.7% of female children being left-handed. Overall, around 90% of people are right-handed. Handedness is often defined by one's writing hand. It is fairly common for people to prefer to do a particular task with a particular hand. Mixed-handed people change hand preference depending on the task.",
    "type": "categorical label"
  },
  {
    "term": "left handed",
    "definition": "In human biology, handedness refers to the tendency of individuals to favor one hand, known as the dominant hand, which is typically stronger, quicker, or more skilled, while the other hand, often less capable and referred to as the non-dominant hand, is not preferred; a 1975 study involving 7,688 children in grades 1–6 in the US found that left-handed individuals made up 9.6% of the participants, with 10.5% of boys and 8.7% of girls being left-handed, and about 90% of the population being right-handed; handedness is frequently associated with the hand used for writing, and it is common for individuals to have a preferred hand for specific",
    "type": "categorical label"
  },
  {
    "term": "pN1a (colon)",
    "definition": "pN1a (colon) denotes the existence of malignant lymph nodes within the local region, specifically indicating that one to three adjacent lymph nodes are involved in the spread of colon cancer.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN1a (colon)",
    "definition": "pN1a (colon) indicates the occurrence of cancerous lymph nodes in the vicinity, specifically showing that one to three local lymph nodes are involved in the metastatic process of colon cancer.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN1a (colon)",
    "definition": "pN1a (colon) refers to the presence of cancerous lymph nodes in the regional area, specifically indicating that one to three nearby lymph nodes are affected by metastasis in colon cancer.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pN1a (colon)",
    "definition": "pN1a (colon) signifies the presence of neoplastic lymph nodes in the surrounding area, particularly indicating that one to three nearby lymph nodes are impacted by metastatic colon cancer.",
    "type": "pathologic lymph node stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "zip",
    "definition": "\"The terms Zip, Zips, or ZIP might signify:\"",
    "type": "data format specification"
  },
  {
    "term": "zip",
    "definition": "\"Zip, Zips, or ZIP could denote:\"",
    "type": "data format specification"
  },
  {
    "term": "zip",
    "definition": "\"Zip, Zips, or ZIP may indicate:\"",
    "type": "data format specification"
  },
  {
    "term": "zip",
    "definition": "Zip, Zips or ZIP may refer to:",
    "type": "data format specification"
  },
  {
    "term": "gram",
    "definition": "A gram, in the context of the International System of Units (SI), represents a unit of mass that is equal to 0.001 kilograms.",
    "type": "mass unit"
  },
  {
    "term": "gram",
    "definition": "In the International System of Units (SI), a gram is defined as a mass unit that is one thousandth of a kilogram.",
    "type": "mass unit"
  },
  {
    "term": "gram",
    "definition": "The gram is a mass measurement in the International System of Units (SI) that is equivalent to one-thousandth of a kilogram.",
    "type": "mass unit"
  },
  {
    "term": "gram",
    "definition": "The gram is a unit of mass in the International System of Units (SI) equal to one thousandth of a kilogram.",
    "type": "mass unit"
  },
  {
    "term": "40-50: symptomatic, in bed more than 50% of the day, but not bed ridden",
    "definition": "\"40-50\" denotes a condition in which a person encounters symptoms that restrict their daily activities, necessitating that they remain in bed for over half the day, yet they are not entirely incapacitated from getting up.",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "40-50: symptomatic, in bed more than 50% of the day, but not bed ridden",
    "definition": "\"40-50\" indicates a level of health where a person faces symptoms that curtail their activity, forcing them to lie in bed for more than half the day, while still being capable of getting out of bed.",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "40-50: symptomatic, in bed more than 50% of the day, but not bed ridden",
    "definition": "\"40-50\" refers to a state where an individual experiences symptoms that limit their activity, requiring them to spend more than half of the day in bed, but they are not completely unable to get out of bed.",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "40-50: symptomatic, in bed more than 50% of the day, but not bed ridden",
    "definition": "The term \"40-50\" describes a situation where an individual suffers from symptoms that hinder their ability to engage in activities, leading them to stay in bed for more than 50% of the day, though they can still manage to rise from bed.",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "cubic centimeter",
    "definition": "A cubic centimeter is a frequently utilized volume measurement equivalent to the space occupied by a cube with dimensions of 1 cm on each side; it is also equal to one milliliter, and at a temperature of 3.98 °C, the weight of one cubic centimeter of water is nearly one gram.",
    "type": "volume unit"
  },
  {
    "term": "cubic centimeter",
    "definition": "A cubic centimeter serves as a standard unit of volume representing the capacity of a cube measuring 1 cm per side, which is equal to one milliliter, and the mass of this volume of water at 3.98 °C is approximately one gram.",
    "type": "volume unit"
  },
  {
    "term": "cubic centimeter",
    "definition": "A cubic centimetre is a commonly used unit of volume that corresponds to the volume of a cube that measures 1 cm × 1 cm × 1 cm. One cubic centimetre corresponds to a volume of one millilitre. The mass of one cubic centimetre of water at 3.98 °C is almost equal to one gram.",
    "type": "volume unit"
  },
  {
    "term": "cubic centimeter",
    "definition": "The cubic centimeter, a widely accepted volume unit, reflects the volume of a cube with sides of 1 cm, equating to one milliliter, and",
    "type": "volume unit"
  },
  {
    "term": "milliliter",
    "definition": "The liter, also spelled litre, is a metric volume measurement equivalent to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³); a cubic decimeter represents a volume of 10 cm by 10 cm by 10 cm, making it one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "milliliter",
    "definition": "The litre (or liter) serves as a metric volume unit, corresponding to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), where a cubic decimeter has a volume of 10 cm × 10 cm × 10 cm, thus representing one-thousandth of a cubic",
    "type": "volume unit"
  },
  {
    "term": "milliliter",
    "definition": "The litre or liter is a metric unit of volume. It is equal to 1 cubic decimetre (dm3), 1000 cubic centimetres (cm3) or 0.001 cubic metres (m3). A cubic decimetre occupies a volume of 10 cm × 10 cm × 10 cm and is thus equal to one-thousandth of a cubic metre.",
    "type": "volume unit"
  },
  {
    "term": "month",
    "definition": "A month functions as a time interval recognized in calendars, approximately matching the duration of a natural lunar phase.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "A month is a time measurement, utilized in calendars, that roughly corresponds to the duration of a natural lunar phase cycle.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "A month is a unit of time, used with calendars, that is approximately as long as a natural phase cycle of the Moon",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "A month serves as a temporal unit in calendars and is roughly equivalent to the length of a natural cycle of the Moon.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "Lunar months, referred to as \"lunations,\" are synodic months that last around 29.53 days, resulting in about 12.37 of these months per Earth year; evidence from ancient tally sticks indicates that humans tracked days according to the Moon's phases since the Paleolithic era, and synodic months, determined by the Moon's orbit in relation to the Earth and Sun, continue to underpin numerous modern calendars and year divisions.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "Month and Moon are etymologically related, with the idea of months originating from the phases of the Moon.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "The term \"lunations\" describes lunar months, which are synodic in nature and have an average duration of 29.53 days, leading to about 12.37 such months within a single Earth year; archaeological findings from tally sticks suggest that day counting in relation to the",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "The terms month and Moon share a common linguistic origin, as the conventional understanding of months developed alongside the lunar cycle.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "The words month and Moon are derived from the same root, reflecting that the traditional notion of months is linked to the lunar phases.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "such lunar months (\"lunations\") are synodic months and last approximately 29.53 days, making for roughly 12.37 such months in one Earth year. From excavated tally sticks, researchers have deduced that people counted days in relation to the Moon's phases as early as the Paleolithic age. Synodic months, based on the Moon's orbital period with respect to the Earth–Sun line, are still the basis of many calendars today and are used to divide the year.",
    "type": "time unit"
  },
  {
    "term": "month",
    "definition": "the words month and Moon are cognates. The traditional concept of months arose with the cycle of Moon phases",
    "type": "time unit"
  },
  {
    "term": "milligram",
    "definition": "In the International System of Units (SI), the kilogram is the primary mass unit, corresponding to one thousand grams and denoted by the symbol kg; the term \"kilogram\" is created by merging the metric prefix kilo- with gram.",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "It is casually condensed to \"kilo.\"",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "It is commonly abbreviated to \"kilo.\"",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "It is informally referred to as \"kilo.\"",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "The kilogram is the base unit of mass in the International System of Units (SI), equal to one thousand grams. It has the unit symbol kg. The word \"kilogram\" is formed from the combination of the metric prefix kilo- and gram",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "The kilogram serves as the fundamental unit of mass in the International System of Units (SI), equivalent to one thousand grams, represented by the symbol kg; its name derives from the combination of the metric prefix kilo- and the term gram.",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "The kilogram, which is the standard unit of mass in the International System of Units (SI) and equals one thousand grams, is abbreviated as kg; the name \"kilogram\" is a blend of the prefix kilo- and the word gram.",
    "type": "mass unit"
  },
  {
    "term": "milligram",
    "definition": "it is colloquially shortened to \"kilo\".",
    "type": "mass unit"
  },
  {
    "term": "pN0 (kidney)",
    "definition": "pN0 (kidney) denotes that there is no involvement of regional lymph nodes in the staging process of kidney cancer.",
    "type": "pathologic lymph node stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pN0 (kidney)",
    "definition": "pN0 (kidney) indicates that there is no regional lymph node involvement in the staging of kidney cancer.",
    "type": "pathologic lymph node stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pN0 (kidney)",
    "definition": "pN0 (kidney) reflects the lack of regional lymph node involvement in the staging criteria for kidney cancer.",
    "type": "pathologic lymph node stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pN0 (kidney)",
    "definition": "pN0 (kidney) signifies the absence of regional lymph node involvement in the classification of kidney cancer.",
    "type": "pathologic lymph node stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "GenePattern module HeatMapViewer",
    "definition": "GenePattern's HeatMapViewer is a utility that transforms complex data sets into heat maps, making it easier for users to analyze and understand patterns and interrelations in gene expression and various quantitative data.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module HeatMapViewer",
    "definition": "The GenePattern module HeatMapViewer is a tool that visualizes complex data sets as heat maps, allowing users to easily interpret patterns and relationships in gene expression or other quantitative data.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module HeatMapViewer",
    "definition": "The HeatMapViewer component of GenePattern is designed to represent complex data sets through heat maps, facilitating the straightforward interpretation of patterns and relationships in gene expression and other quantitative metrics.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module HeatMapViewer",
    "definition": "The HeatMapViewer module in GenePattern serves as a tool for visualizing intricate data sets in the form of heat maps, enabling users to readily discern patterns and correlations in gene expression or other quantitative information.",
    "type": "GenePattern software"
  },
  {
    "term": "G2: Moderately differentiated",
    "definition": "G2: Moderately differentiated describes tumor cells that display certain features of normal cells while also presenting significant irregularities, reflecting a middle ground of differentiation between well-differentiated and poorly differentiated tumors.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "G2: Moderately differentiated",
    "definition": "G2: Moderately differentiated indicates a category of tumor cells that possess some traits of normal cells yet reveal considerable deviations, suggesting a moderate degree of differentiation lying between well and poorly differentiated tumors.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "G2: Moderately differentiated",
    "definition": "G2: Moderately differentiated refers to a classification of tumor cells that exhibit some characteristics of normal cells but also show notable abnormalities, indicating an intermediate level of differentiation between well-differentiated and poorly differentiated tumors.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "G2: Moderately differentiated",
    "definition": "G2: Moderately differentiated signifies a type of tumor cell that retains some normal cell characteristics, alongside marked abnormalities, representing an intermediate differentiation status between well-differentiated and poorly differentiated tumors.",
    "type": "histologic grade according to AJCC 7th edition"
  },
  {
    "term": "UO_0000196",
    "definition": "UO_0000196 denotes the quantification of urine output generated by an organism within a defined timeframe.",
    "type": "concentration unit"
  },
  {
    "term": "UO_0000196",
    "definition": "UO_0000196 indicates a measurement of the quantity of urine generated by an organism in a specified time interval.",
    "type": "concentration unit"
  },
  {
    "term": "UO_0000196",
    "definition": "UO_0000196 refers to a measurement of the volume of urine produced by an organism over a specified period of time.",
    "type": "concentration unit"
  },
  {
    "term": "UO_0000196",
    "definition": "UO_0000196 signifies the assessment of the amount of urine excreted by an organism during a particular duration.",
    "type": "concentration unit"
  },
  {
    "term": "Li-Cor",
    "definition": "Li-Cor is a company that develops and manufactures advanced instruments and technologies for life science research, including systems for measuring fluorescence and infrared imaging.",
    "type": "manufacturer"
  },
  {
    "term": "Li-Cor",
    "definition": "Li-Cor is a corporation engaged in the development and production of sophisticated instruments and technologies for life science investigations, featuring systems for fluorescence detection and infrared imaging.",
    "type": "manufacturer"
  },
  {
    "term": "Li-Cor",
    "definition": "Li-Cor is a firm that designs and produces cutting-edge tools and technologies for research in life sciences, such as devices for fluorescence measurement and infrared imaging.",
    "type": "manufacturer"
  },
  {
    "term": "Li-Cor",
    "definition": "Li-Cor is an enterprise that creates and manufactures innovative devices and technologies for life science studies, including systems for measuring fluorescence and capturing infrared images.",
    "type": "manufacturer"
  },
  {
    "term": "GenePattern module SVM",
    "definition": "The GenePattern SVM module functions as a computational tool that utilizes support vector machine methods to sort and investigate biological data, for instance, gene expression patterns.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module SVM",
    "definition": "The GenePattern module SVM is a computational tool that uses support vector machine algorithms to classify and analyze biological data, such as gene expression profiles.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module SVM",
    "definition": "The SVM component of GenePattern serves as a computational resource that applies support vector machine algorithms for the classification and analysis of biological datasets, like gene expression profiles.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module SVM",
    "definition": "The SVM module in GenePattern is a software application that employs support vector machine techniques to categorize and examine biological information, including gene expression data.",
    "type": "GenePattern software"
  },
  {
    "term": "60-70: symptomatic but in bed less than 50% of the day",
    "definition": "\"60-70: symptomatic but spends less than half the day in bed due to illness.\"",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "60-70: symptomatic but in bed less than 50% of the day",
    "definition": "1. \"Individuals aged 60 to 70 exhibit symptoms but remain in bed for less than half the day because of their condition.\"",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "60-70: symptomatic but in bed less than 50% of the day",
    "definition": "2. \"People between the ages of 60 and 70 show symptoms yet lie in bed for under half of the day due to their illness.\"",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "60-70: symptomatic but in bed less than 50% of the day",
    "definition": "3. \"Those aged 60 to 70 are symptomatic but spend fewer than 12 hours a day in bed as a result of their health issues.\"",
    "type": "Karnofsky score vaue specification"
  },
  {
    "term": "millimeter",
    "definition": "A millimetre, or millimeter, is a length unit within the International System of Units (SI)",
    "type": "length unit"
  },
  {
    "term": "millimeter",
    "definition": "The millimetre (or millimeter) is a metric length measurement in the International System of Units (SI), representing one-thousandth of a metre, the fundamental SI unit for length; thus, a metre comprises one thousand millimetres, and a centimetre contains ten millimetres.",
    "type": "length unit"
  },
  {
    "term": "millimeter",
    "definition": "The millimetre or millimeter is a unit of length in the International System of Units (SI), equal to one thousandth of a metre, which is the SI base unit of length. Therefore, there are one thousand millimetres in a metre, and there are ten millimetres in a centimetre.",
    "type": "length unit"
  },
  {
    "term": "millimeter",
    "definition": "The millimetre, also spelled millimeter, is a length unit in the International System of Units (SI), defined as one-thousandth of a metre, the primary SI length unit; consequently, there are 1,000 millimetres in a metre and 10 millimetres in a centimetre.",
    "type": "length unit"
  },
  {
    "term": "GenePattern k-means clustering",
    "definition": "GenePattern k-means clustering is a computational method used to group gene expression data into distinct clusters based on similarity, helping to identify patterns and relationships in biological data.",
    "type": "k-means clustering"
  },
  {
    "term": "GenePattern k-means clustering",
    "definition": "GenePattern's k-means clustering is a computational technique employed to categorize gene expression data into separate clusters based on their similarities, facilitating the discovery of patterns and connections within biological information.",
    "type": "k-means clustering"
  },
  {
    "term": "GenePattern k-means clustering",
    "definition": "In GenePattern, k-means clustering serves as a computational strategy for sorting gene expression data into distinct groups based on similarity, which aids in uncovering patterns and associations in biological data.",
    "type": "k-means clustering"
  },
  {
    "term": "GenePattern k-means clustering",
    "definition": "The k-means clustering method in GenePattern is an analytical approach that organizes gene expression data into unique clusters according to their similarity, aiding in the identification of patterns and relationships in biological datasets.",
    "type": "k-means clustering"
  },
  {
    "term": "Beckman Coulter",
    "definition": "As a part of Danaher Corporation, Beckman Coulter, Inc. focuses on creating, producing, and selling products associated with biomedical testing, operating in the diagnostics sector under the Beckman Coulter name and in life sciences as Beckman Coulter Life Sciences; the company began in 1935 as National Technical Laboratories and has grown into a",
    "type": "manufacturer"
  },
  {
    "term": "Beckman Coulter",
    "definition": "Beckman Coulter, Inc. is a Danaher Corporation company that develops, manufactures, and markets products relevant to biomedical testing. It operates in the industries of diagnostics under the brand name Beckman Coulter and life sciences under the brand name Beckman Coulter Life Sciences. The company was established in 1935 as National Technical Laboratories, and has become an international company through growth and acquisitions of other life sciences organizations.",
    "type": "manufacturer"
  },
  {
    "term": "Beckman Coulter",
    "definition": "Beckman Coulter, Inc., a subsidiary of Danaher Corporation, specializes in the development, production, and distribution of biomedical testing products, functioning in the diagnostic sector under the Beckman Coulter brand and in life sciences as Beckman Coulter Life Sciences; originally founded in 1935 as National Technical Laboratories, the firm has expanded globally through growth and acquisitions in the life sciences field.",
    "type": "manufacturer"
  },
  {
    "term": "GenePattern module KNNXValidation",
    "definition": "KNNXValidation, a module within GenePattern, is utilized for measuring the performance of k-nearest neighbors classification by validating the model's accuracy through various cross-validation strategies.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KNNXValidation",
    "definition": "The GenePattern KNNXValidation tool is designed to assess the performance of k-nearest neighbors classification by verifying the model's accuracy with cross-validation approaches.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KNNXValidation",
    "definition": "The GenePattern module KNNXValidation is a tool used for evaluating the performance of k-nearest neighbors classification by validating the model's accuracy through cross-validation techniques.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module KNNXValidation",
    "definition": "The KNNXValidation module in GenePattern serves as a resource for assessing the effectiveness of k-nearest neighbors classification by confirming the model's precision using cross-validation methods.",
    "type": "GenePattern software"
  },
  {
    "term": "picomolar",
    "definition": "As an illustration, the hydronium ion [H3O+] is present at a concentration of 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "picomolar",
    "definition": "For instance, the concentration of the hydronium ion [H3O+] is 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "picomolar",
    "definition": "Molar concentration (also called amount-of-substance concentration or molarity) is the number of moles of solute per liter of solution. Specifically, It is a measure of the concentration of a chemical species, in particular, of a solute in a solution, in terms of amount of substance per unit volume of solution. In chemistry, the most commonly used unit for molarity is the number of moles per liter, having the unit symbol mol/L or mol/dm3 (1000 mol/m3) in SI units. Molar concentration is often depicted with square brackets around the substance of interest",
    "type": "concentration unit"
  },
  {
    "term": "picomolar",
    "definition": "Molar concentration, known as molarity or amount-of-substance concentration, defines the number of moles of a solute contained in a liter of solution, providing a measure of the concentration of a chemical species in relation to the volume of the",
    "type": "concentration unit"
  },
  {
    "term": "picomolar",
    "definition": "Molar concentration, referred to as amount-of-substance concentration or molarity, quantifies the moles of solute present in one liter of solution, serving as an indicator of a chemical species' concentration in a solution expressed as moles per unit volume; in chemistry, it is typically represented in units of moles per liter (mol/L or mol/dm³, equivalent to 1000 mol/m³ in SI), and is commonly denoted with square brackets around the relevant substance.",
    "type": "concentration unit"
  },
  {
    "term": "picomolar",
    "definition": "To illustrate, the concentration of the hydronium ion [H3O+] is measured at 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "picomolar",
    "definition": "for example with the hydronium ion [H3O+] = 4.57 x 10-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "degree Celsius",
    "definition": "The Celsius degree is the measurement unit for temperature on the Celsius scale, one of the two temperature scales recognized in the International System of Units (SI), alongside the Kelvin scale. It can denote a specific temperature on the Celsius scale or indicate a temperature difference or range. This unit is named after the Swedish astronomer Anders Celsius (1701–1744), who introduced the initial version in 1742. For many years, it was referred to as centigrade in several languages. In 1948, the International Committee for Weights and Measures renamed it to honor Celsius and to eliminate confusion with the term for one hundredth of a gradian used in some languages. The Celsius scale is predominantly used worldwide.",
    "type": "temperature unit"
  },
  {
    "term": "degree Celsius",
    "definition": "The degree Celsius is the unit of temperature on the Celsius temperature scale, one of two temperature scales used in the International System of Units (SI), the other being the closely related Kelvin scale. The degree Celsius can refer to a specific point on the Celsius temperature scale or to a difference or range between two temperatures. It is named after the Swedish astronomer Anders Celsius (1701–1744), who proposed the first version of it in 1742. The unit was called centigrade in several languages for many years. In 1948, the International Committee for Weights and Measures renamed it to honor Celsius and also to remove confusion with the term for one hundredth of a gradian in some languages. Most countries use this scale.",
    "type": "temperature unit"
  },
  {
    "term": "degree Celsius",
    "definition": "The degree Celsius serves as",
    "type": "temperature unit"
  },
  {
    "term": "microliter",
    "definition": "The liter, a metric volume measurement, corresponds to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), with a cubic decimeter representing a space of 10 cm × 10 cm × 10 cm, which is equivalent to one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "microliter",
    "definition": "The liter, a unit of volume in the metric system, is defined as 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), where a cubic decimeter has dimensions of 10 cm × 10 cm × 10 cm, making it one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "microliter",
    "definition": "The litre or liter is a metric unit of volume. It is equal to 1 cubic decimetre (dm3), 1000 cubic centimetres (cm3) or 0.001 cubic metres (m3). A cubic decimetre occupies a volume of 10 cm × 10 cm × 10 cm and is thus equal to one-thousandth of a cubic metre.",
    "type": "volume unit"
  },
  {
    "term": "nanoliter",
    "definition": "A liter is a metric volume measurement equivalent to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), where a cubic decimeter is the volume of a cube measuring 10 cm on each side, thus representing one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "nanoliter",
    "definition": "The liter serves as a metric",
    "type": "volume unit"
  },
  {
    "term": "nanoliter",
    "definition": "The liter, a metric volume unit, corresponds to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), with a cubic decimeter defined as the space of 10 cm × 10 cm × 10 cm, making it one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "nanoliter",
    "definition": "The litre or liter is a metric unit of volume. It is equal to 1 cubic decimetre (dm3), 1000 cubic centimetres (cm3) or 0.001 cubic metres (m3). A cubic decimetre occupies a volume of 10 cm × 10 cm × 10 cm and is thus equal to one-thousandth of a cubic metre.",
    "type": "volume unit"
  },
  {
    "term": "picoliter",
    "definition": "The liter or litre is a metric volume measurement equivalent to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), with a cubic decimeter representing a space of 10 cm × 10 cm × 10 cm, which makes it one-thousandth of a cubic meter.",
    "type": "volume unit"
  },
  {
    "term": "picoliter",
    "definition": "The litre or liter is a metric unit of volume. It is equal to 1 cubic decimetre (dm3), 1000 cubic centimetres (cm3) or 0.001 cubic metres (m3). A cubic decimetre occupies a volume of 10 cm × 10 cm × 10 cm and is thus equal to one-thousandth of a cubic metre.",
    "type": "volume unit"
  },
  {
    "term": "picoliter",
    "definition": "The litre, also known as liter, serves as a metric volume unit that corresponds to 1 cubic decimeter (dm³), 1000 cubic centimeters (cm³), or 0.001 cubic meters (m³), where a cubic decimeter has a volume of 10 cm × 10 cm × 10 cm, thereby equating to one-thousandth",
    "type": "volume unit"
  },
  {
    "term": "Apogee Flow Systems",
    "definition": "Apogee Flow Systems denotes a business dedicated to the advancement of sophisticated fluid management technologies and solutions applicable to diverse biomedical fields.",
    "type": "manufacturer"
  },
  {
    "term": "Apogee Flow Systems",
    "definition": "Apogee Flow Systems identifies a company that concentrates on the development of cutting-edge fluid management technologies and solutions for multiple biomedical purposes.",
    "type": "manufacturer"
  },
  {
    "term": "Apogee Flow Systems",
    "definition": "Apogee Flow Systems is a firm focused on creating innovative fluid management technologies and solutions tailored for a range of biomedical uses.",
    "type": "manufacturer"
  },
  {
    "term": "Apogee Flow Systems",
    "definition": "Apogee Flow Systems refers to a company that specializes in developing advanced fluid management technologies and solutions for various biomedical applications.",
    "type": "manufacturer"
  },
  {
    "term": "Stage 3B (FIGO)",
    "definition": "In the FIGO classification, Stage 3B describes cervical cancer where the tumor has infiltrated the lower third of the vagina or pelvic wall and may include involvement of surrounding lymph nodes, without any metastasis to distant sites.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3B (FIGO)",
    "definition": "Stage 3B (FIGO) denotes a category of cervical cancer in which the cancerous tumor has metastasized to the lower third of the vagina or the pelvic wall, and may also affect adjacent lymph nodes, while remaining localized and not spreading to distant areas.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3B (FIGO)",
    "definition": "Stage 3B (FIGO) is a designation for cervical cancer indicating that the tumor has invaded the lower third of the vagina or the pelvic wall and may also involve nearby lymph nodes, but does not extend to distant locations.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3B (FIGO)",
    "definition": "Stage 3B (FIGO) refers to a classification of cervical cancer where the tumor has spread to the lower third of the vagina or to the pelvic wall, and may also involve nearby lymph nodes, but not to distant sites.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "millimolar",
    "definition": "As an illustration, the hydronium ion [H3O+] has a concentration of 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "millimolar",
    "definition": "For instance, the concentration of the hydronium ion [H3O+] is 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "millimolar",
    "definition": "Molar concentration (also called amount-of-substance concentration or molarity) is the number of moles of solute per liter of solution. Specifically, It is a measure of the concentration of a chemical species, in particular, of a solute in a solution, in terms of amount of substance per unit volume of solution. In chemistry, the most commonly used unit for molarity is the number of moles per liter, having the unit symbol mol/L or mol/dm3 (1000 mol/m3) in SI units. Molar concentration is often depicted with square brackets around the substance of interest",
    "type": "concentration unit"
  },
  {
    "term": "millimolar",
    "definition": "Molar concentration, known as amount-of-substance concentration or molarity, quantifies the number of moles of a solute in one liter of solution, serving as an indicator of a chemical species' concentration in a solution, typically expressed in moles per liter (mol/L or mol/dm³) in SI units, and is frequently represented with square brackets surrounding the relevant substance.",
    "type": "concentration unit"
  },
  {
    "term": "millimolar",
    "definition": "Molar concentration, which can also be referred to as amount-of-substance concentration or molarity, is defined as the quantity of solute in moles per liter of solution, indicating the concentration of a chemical species, especially a solute, and is commonly measured in moles per liter (mol/L or mol/dm³) in the International",
    "type": "concentration unit"
  },
  {
    "term": "millimolar",
    "definition": "To illustrate, the concentration of the hydronium ion [H3O+] is measured at 4.57 x 10^-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "millimolar",
    "definition": "for example with the hydronium ion [H3O+] = 4.57 x 10-9 mol/L.",
    "type": "concentration unit"
  },
  {
    "term": "Stage 3C (FIGO)",
    "definition": "Stage 3C (FIGO) denotes an advanced stage of ovarian cancer in which the tumor has disseminated from the pelvis into the abdominal cavity, presenting with peritoneal carcinomatosis featuring tumor nodules larger than 2 cm, or has metastasized to lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3C (FIGO)",
    "definition": "Stage 3C (FIGO) describes a severe stage of ovarian cancer where the tumor has migrated from the pelvic area to the abdominal cavity, involving peritoneal carcin",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3C (FIGO)",
    "definition": "Stage 3C (FIGO) indicates a progressed form of ovarian cancer characterized by the tumor extending beyond the pelvic region into the abdominal cavity, accompanied by peritoneal carcinomatosis with tumor nodules exceeding 2 cm, or metastasis to lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3C (FIGO)",
    "definition": "Stage 3C (FIGO) refers to advanced ovarian cancer where the tumor has spread beyond the pelvis to the abdominal cavity and involves peritoneal carcinomatosis with tumor nodules larger than 2 cm, or has spread to lymph nodes.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "centimeter",
    "definition": "\"Another version of the centimetre measurement.\"",
    "type": "length unit"
  },
  {
    "term": "centimeter",
    "definition": "\"Different representation of a centimetre.\"",
    "type": "length unit"
  },
  {
    "term": "centimeter",
    "definition": "\"Variant expression of a centimetre.\"",
    "type": "length unit"
  },
  {
    "term": "centimeter",
    "definition": "Alternative form of centimetre.",
    "type": "length unit"
  },
  {
    "term": "Miltenyi Biotec",
    "definition": "Based in Bergisch Gladbach near Cologne, Germany, Miltenyi Biotec is a global biotech company that supplies products and services for scientists, clinical researchers, and medical professionals engaged in",
    "type": "manufacturer"
  },
  {
    "term": "Miltenyi Biotec",
    "definition": "Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services for scientists, clinical researchers, and physicians to use in their basic research, translational research, and clinical applications. These services include techniques of sample preparation, cell separation, cell sorting, flow cytometry, spatial biology, cell culture, molecular analysis, clinical applications and small animal imaging. According to Miltenyi Biotec own internal sources, the company states that it has over 3,000 employees in 28 countries and produces more than 17,000 products although this has not been independently verified.",
    "type": "manufacturer"
  },
  {
    "term": "Miltenyi Biotec",
    "definition": "Miltenyi Biotec, a worldwide biotechnology firm based in Bergisch Gladbach near Cologne, Germany, offers a range of products and services aimed at scientists, clinical researchers, and healthcare professionals for use in fundamental research, translational studies, and clinical practices, which encompass sample preparation, cell separation, flow cytometry, spatial biology, cell culture, molecular analysis, and small animal imaging; the company claims to employ over 3,000 individuals across 28 nations and to manufacture more than 17,000 products, though these figures remain unverified.",
    "type": "manufacturer"
  },
  {
    "term": "Bentley Instruments",
    "definition": "Bentley Instruments is a business that concentrates on the design and production of analytical tools for the pharmaceutical and biotech fields, prioritizing quality management and process improvement.",
    "type": "manufacturer"
  },
  {
    "term": "Bentley Instruments",
    "definition": "Bentley Instruments is a company that specializes in the development and manufacturing of analytical instruments for the pharmaceutical and biotechnology industries, focusing on quality control and process optimization.",
    "type": "manufacturer"
  },
  {
    "term": "Bentley Instruments",
    "definition": "Bentley Instruments is a firm dedicated to creating and producing analytical devices tailored for the pharmaceutical and biotechnology sectors, emphasizing quality assurance and process enhancement.",
    "type": "manufacturer"
  },
  {
    "term": "Bentley Instruments",
    "definition": "Bentley Instruments is an organization that focuses on the innovation and fabrication of analytical equipment for the pharmaceutical and biotechnology industries, with an emphasis on ensuring quality and optimizing processes.",
    "type": "manufacturer"
  },
  {
    "term": "pM1 (ovary)",
    "definition": "pM1 (ovary) denotes the existence of metastatic tumor cells within the ovaries, signifying that the malignancy has disseminated from its primary site to this particular area.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pM1 (ovary)",
    "definition": "pM1 (ovary) indicates the presence of cancer cells that have metastasized to the ovaries, suggesting that the disease has extended from its original location to this specific site.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pM1 (ovary)",
    "definition": "pM1 (ovary) refers to the presence of metastatic cancer cells in the ovaries, indicating that the cancer has spread beyond its original site to this specific location.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pM1 (ovary)",
    "definition": "pM1 (ovary) signifies the occurrence of metastatic cancer cells in the ovaries, demonstrating that the cancer has progressed from its initial site to this specific region.",
    "type": "pathologic distant metastases stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT1 (colon)",
    "definition": "pT1 (colon) denotes a stage of colon cancer characterized by the tumor's invasion into the submucosal layer without breaching the deeper layers of the colonic wall.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT1 (colon)",
    "definition": "pT1 (colon) describes a classification of colon cancer where the tumor has extended into the submucosal region but has not affected the deeper structures of the colon wall.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT1 (colon)",
    "definition": "pT1 (colon) refers to a classification of colon cancer where the tumor has invaded the submucosa but has not penetrated deeper layers of the colon wall.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT1 (colon)",
    "definition": "pT1 (colon) signifies a category of colon cancer in which the tumor has infiltrated the submucosa while remaining confined to the outer layers of the colon wall.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT0 (colon)",
    "definition": "pT0 (colon) denotes that there is no indication of a primary tumor present in the colon, indicating that the cancer has not infiltrated the colon tissue.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT0 (colon)",
    "definition": "pT0 (colon) indicates that there is no evidence of primary tumor in the colon, suggesting that the cancer has not invaded the colon tissue.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT0 (colon)",
    "definition": "pT0 (colon) reflects that there is no detectable primary tumor in the colon, suggesting that the cancer has not encroached upon the colon's tissue.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT0 (colon)",
    "definition": "pT0 (colon) signifies the absence of any signs of a primary tumor in the colon, implying that the cancer has not penetrated the colon's tissue.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "Oxford Nanopore Technologies",
    "definition": "Based in the UK, Oxford Nanopore Technologies plc creates and markets nanopore sequencing solutions for the electronic analysis of single molecules and is listed on the London Stock Exchange as a member of the FTSE 250 Index.",
    "type": "manufacturer"
  },
  {
    "term": "Oxford Nanopore Technologies",
    "definition": "Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products for the direct, electronic analysis of single molecules. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.",
    "type": "manufacturer"
  },
  {
    "term": "Oxford Nanopore Technologies",
    "definition": "Oxford Nanopore Technologies plc, a UK-based firm, focuses on creating and distributing nanopore sequencing products that enable the electronic examination of single molecules, and it is listed on the London Stock Exchange while being included in the FTSE 250",
    "type": "manufacturer"
  },
  {
    "term": "Oxford Nanopore Technologies",
    "definition": "Oxford Nanopore Technologies plc, a company located in the UK, specializes in the development and sale of nanopore sequencing technologies designed for the electronic analysis of individual molecules; it is publicly traded on the London Stock Exchange and is part of the FTSE 250 Index.",
    "type": "manufacturer"
  },
  {
    "term": "Becton Dickinson (BD Biosciences)",
    "definition": "As a global leader in medical technology, Becton Dickinson (BD Biosciences) designs and manufactures innovative systems and tools aimed at advancing research, clinical diagnostics, and biomanufacturing in the life sciences industry.",
    "type": "manufacturer"
  },
  {
    "term": "Becton Dickinson (BD Biosciences)",
    "definition": "BD Biosciences, a division of Becton Dickinson, operates worldwide in the medical technology arena, focusing on the development and production of cutting-edge tools and systems for research, clinical diagnostics, and biomanufacturing in life sciences.",
    "type": "manufacturer"
  },
  {
    "term": "Becton Dickinson (BD Biosciences)",
    "definition": "Becton Dickinson (BD Biosciences) is a global medical technology company that develops and manufactures innovative tools and systems for research, clinical diagnostics, and biomanufacturing in the life sciences sector.",
    "type": "manufacturer"
  },
  {
    "term": "Becton Dickinson (BD Biosciences)",
    "definition": "Becton Dickinson (BD Biosciences) is an international company specializing in medical technology, creating and producing advanced instruments and systems for research, clinical diagnostics, and biomanufacturing within the life sciences field.",
    "type": "manufacturer"
  },
  {
    "term": "pT2b (kidney)",
    "definition": "The term pT2b (kidney) describes a type of kidney cancer in which the tumor measures over 7 centimeters and remains localized within the kidney.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2b (kidney)",
    "definition": "pT2b (kidney) denotes a category of kidney cancer characterized by a tumor exceeding 7 centimeters in size that has not metastasized outside the kidney.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2b (kidney)",
    "definition": "pT2b (kidney) indicates a classification of renal cancer where the tumor size is greater than 7 centimeters and has not extended beyond the kidney.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "pT2b (kidney)",
    "definition": "pT2b (kidney) refers to a classification of kidney cancer where the tumor is larger than 7 centimeters and has not spread beyond the kidney.",
    "type": "pathologic primary tumor stage for kidney according to AJCC 7th edition"
  },
  {
    "term": "1: symptomatic but fully ambulatory",
    "definition": "\"1: 'symptomatic but fully ambulatory' describes a state in which a person shows signs of a disease or condition yet retains the ability to walk and move independently.\"",
    "type": "Eastern Cooperative Oncology Group score value specification"
  },
  {
    "term": "1: symptomatic but fully ambulatory",
    "definition": "\"1: 'symptomatic but fully ambulatory' signifies a scenario in which an individual presents symptoms of an ailment but is capable of independent mobility.\"",
    "type": "Eastern Cooperative Oncology Group score value specification"
  },
  {
    "term": "1: symptomatic but fully ambulatory",
    "definition": "\"1: The term 'symptomatic but fully ambulatory' indicates a situation where a person displays symptoms of a health issue while still being capable of walking and moving without assistance.\"",
    "type": "Eastern Cooperative Oncology Group score value specification"
  },
  {
    "term": "1: symptomatic but fully ambulatory",
    "definition": "\"1: symptomatic but fully ambulatory\" refers to a condition where an individual exhibits symptoms of an illness or disorder but is still able to walk and move around independently.",
    "type": "Eastern Cooperative Oncology Group score value specification"
  },
  {
    "term": "cM0 (colon)",
    "definition": "In the context of colon cancer staging, cM0 (colon) indicates that there is no indication of distant metastasis present.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "cM0 (colon)",
    "definition": "cM0 (colon) denotes a classification signifying the absence of detectable distant metastasis in the staging system for colon cancer.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "cM0 (colon)",
    "definition": "cM0 (colon) is a term used to classify the situation where no distant metastasis is found in the colon cancer staging criteria.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "cM0 (colon)",
    "definition": "cM0 (colon) refers to a classification indicating that there is no evidence of distant metastasis in the colon cancer staging system.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "pT1b (lung)",
    "definition": "pT1b (lung) denotes a category of lung cancer characterized by a tumor measuring between 3 and 4 centimeters at its largest point, which remains localized within the lung and does not infiltrate adjacent tissues.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1b (lung)",
    "definition": "pT1b (lung) is a classification for lung cancer where the tumor is between 3 and 4 centimeters in its largest dimension and is limited to the lung, lacking invasion into nearby anatomical areas.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1b (lung)",
    "definition": "pT1b (lung) refers to a classification of lung cancer where the tumor is 3 to 4 centimeters in greatest dimension and is confined to the lung without invasion of nearby structures.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT1b (lung)",
    "definition": "pT1b (lung) signifies a type of lung cancer in which the tumor size ranges from 3 to 4 centimeters and is restricted to the lung, with no encroachment on surrounding structures.",
    "type": "pathologic primary tumor stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pT4a (colon)",
    "definition": "The term pT4a (colon) describes a stage of colon cancer where the tumor has breached the visceral peritoneum, while remaining free from involvement with other organs or anatomical structures.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4a (colon)",
    "definition": "pT4a (colon) denotes a category of colon cancer in which the tumor has invaded the visceral peritoneum yet does not affect adjacent organs or tissues.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4a (colon)",
    "definition": "pT4a (colon) is a designation for colon cancer characterized by tumor invasion through the visceral peritoneum without involvement of surrounding organs or structures.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4a (colon)",
    "definition": "pT4a (colon) refers to a classification of colon cancer where the tumor has penetrated through the visceral peritoneum but does not involve other organs or structures.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "G4 (WHO)",
    "definition": "G4 (WHO) denotes a set of four critical pathogens recognized by the World Health Organization that present considerable risks to global health because of their ability to trigger outbreaks and pandemics.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G4 (WHO)",
    "definition": "G4 (WHO) describes a category of four urgent pathogens designated by the World Health Organization that represent serious dangers to global health owing to their capacity to initiate outbreaks and pandemics.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G4 (WHO)",
    "definition": "G4 (WHO) refers to a group of four high-priority pathogens identified by the World Health Organization that pose significant threats to global health due to their potential to cause outbreaks and pandemics.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "G4 (WHO)",
    "definition": "G4 (WHO) signifies a collection of four major pathogens highlighted by the World Health Organization that threaten global health significantly due to their potential to lead to outbreaks and pandemics.",
    "type": "histologic grade for ovarian tumor according to the World Health Organization"
  },
  {
    "term": "Stage IIIB (AJCC 7th)",
    "definition": "Stage IIIB (AJCC 7th) describes a cancer stage in which the tumor has disseminated to nearby lymph nodes and might have penetrated adjacent tissues, yet has not metastasized to far-off regions.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIIB (AJCC 7th)",
    "definition": "Stage IIIB (AJCC 7th) designates a cancer classification indicating that the tumor has extended to adjacent lymph nodes and potentially infiltrated nearby tissues, though it has not spread to distant locations.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIIB (AJCC 7th)",
    "definition": "Stage IIIB (AJCC 7th) is a cancer category that signifies the tumor's spread to local lymph nodes and possible encroachment into surrounding tissues, while remaining non-metastatic to distant areas.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "Stage IIIB (AJCC 7th)",
    "definition": "Stage IIIB (AJCC 7th) refers to a classification of cancer where the tumor has spread to nearby lymph nodes and may have invaded surrounding tissues, but has not metastasized to distant sites.",
    "type": "clinical tumor stage group according to AJCC 7th edition"
  },
  {
    "term": "milligram per milliliter",
    "definition": "A milligram per milliliter is a concentration measurement indicating the mass of a substance in milligrams found in a single milliliter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "milligram per milliliter",
    "definition": "A milligram per milliliter is a unit of concentration that expresses the mass of a substance in milligrams contained in one milliliter of solution.",
    "type": "concentration unit"
  },
  {
    "term": "milligram per milliliter",
    "definition": "A milligram per milliliter represents a unit of concentration that denotes the amount of a substance in milligrams within one milliliter of a solution.",
    "type": "concentration unit"
  },
  {
    "term": "milligram per milliliter",
    "definition": "A milligram per milliliter serves as a unit of concentration that quantifies the mass of a substance in milligrams present in each milliliter of a solution.",
    "type": "concentration unit"
  },
  {
    "term": "count per molar",
    "definition": "Count per molar is a measure of the number of entities, such as molecules or particles, present in one mole of a substance, typically expressed in terms of counts per liter.",
    "type": "rate unit"
  },
  {
    "term": "count per molar",
    "definition": "Count per mole refers to the measurement of how many entities, such as molecules or particles, exist in one mole of a substance, commonly conveyed in counts per liter.",
    "type": "rate unit"
  },
  {
    "term": "count per molar",
    "definition": "The count per mole quantifies the quantity of entities, like molecules or particles, found in a single mole of a substance, usually represented as counts per liter.",
    "type": "rate unit"
  },
  {
    "term": "count per molar",
    "definition": "The number of entities, including molecules or particles, in one mole of a substance is indicated by the count per mole, which is generally expressed in counts per liter.",
    "type": "rate unit"
  },
  {
    "term": "out of scope",
    "definition": "In project management, scope is the defined features and functions of a product, or the scope of work needed to finish a project. Scope involves getting information required to start a project, including the features the product needs to meet its stakeholders' requirements.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "out of scope",
    "definition": "In project management, the scope refers to the specified characteristics and functionalities of a product, as well as the tasks necessary to complete a project; it encompasses gathering the information needed to initiate a project, which includes identifying the features essential for fulfilling the expectations of stakeholders.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "out of scope",
    "definition": "In the realm of project management, scope denotes the outlined attributes and operations of a product, along with the work required to achieve project completion; it entails collecting the necessary information to commence a project, including the features that must be incorporated to satisfy stakeholder demands.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "out of scope",
    "definition": "Within project management, scope signifies the established specifications and capabilities of a product, as well as the workload necessary for project completion; it involves acquiring the information needed to launch a project, which includes determining the features that need",
    "type": "obsolescence reason specification"
  },
  {
    "term": "GenePattern module CARTXValidation",
    "definition": "CARTXValidation, a module within GenePattern, functions as a tool for measuring the performance and credibility of predictive models in cancer research by checking their accuracy against external datasets.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module CARTXValidation",
    "definition": "The CARTXValidation module in GenePattern serves as a resource for evaluating the efficacy and dependability of predictive models in oncology by verifying their precision with independent datasets.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module CARTXValidation",
    "definition": "The GenePattern module CARTXValidation is a tool designed to assess the performance and reliability of predictive models in cancer research by validating their accuracy against independent datasets.",
    "type": "GenePattern software"
  },
  {
    "term": "GenePattern module CARTXValidation",
    "definition": "The GenePattern module known as CARTXValidation is intended to evaluate the effectiveness and trustworthiness of predictive models in cancer studies by confirming their accuracy using separate datasets.",
    "type": "GenePattern software"
  },
  {
    "term": "Stage IA1 (FIGO)",
    "definition": "Stage IA1 (FIGO) denotes a preliminary phase of cervical cancer characterized by the presence of invasive cancer limited to the cervix, with a stromal invasion depth of 5 millimeters or less and a horizontal extent not exceeding 7 millimeters.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IA1 (FIGO)",
    "definition": "Stage IA1 (FIGO) describes an early stage of cervical cancer where invasive disease is localized to the cervix, with a maximum depth of stromal invasion of 5 millimeters and a horizontal spread not greater than",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IA1 (FIGO)",
    "definition": "Stage IA1 (FIGO) indicates an initial stage of cervical cancer in which invasive carcinoma is restricted to the cervix, exhibiting a stromal invasion depth of no more than 5 millimeters and a horizontal spread of 7 millimeters or less.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "Stage IA1 (FIGO)",
    "definition": "Stage IA1 (FIGO) refers to a very early stage of cervical cancer where invasive cancer is present but is confined to the cervix and measures 5 millimeters or less in depth of stromal invasion and 7 millimeters or less in horizontal spread.",
    "type": "International Federation of Gynecology and Obstetrics cervical cancer stage value specification"
  },
  {
    "term": "pT3c (ovary)",
    "definition": "pT3c (ovary) denotes a stage of ovarian cancer characterized by the tumor's extension to the peritoneum and/or its spread to the lymph nodes, indicating significant tumor presence.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3c (ovary)",
    "definition": "pT3c (ovary) describes a classification of ovarian cancer that indicates the tumor has disseminated to the peritoneum and/or has spread to the lymph nodes, reflecting extensive tumor involvement.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3c (ovary)",
    "definition": "pT3c (ovary) refers to a classification of ovarian cancer indicating that the tumor has spread to the peritoneum and/or has metastasized to the lymph nodes, with extensive tumor involvement.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "pT3c (ovary)",
    "definition": "pT3c (ovary) signifies a categorization of ovarian cancer where the tumor has invaded the peritoneal cavity and/or has metastasized to the lymphatic system, showing considerable tumor engagement.",
    "type": "pathologic primary tumor stage for ovary according to AJCC 7th edition"
  },
  {
    "term": "Stage 3A (FIGO)",
    "definition": "In the FIGO classification, Stage 3A indicates a form of cervical cancer where the tumor has infiltrated the lower third of the vagina or the pelvic wall, but has not affected the lymph nodes or spread to other distant areas.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3A (FIGO)",
    "definition": "Stage 3A (FIGO) denotes a category of cervical cancer in which the malignancy has extended to the lower third of the vagina or the pelvic wall, without involvement of the lymph nodes or any distant locations.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3A (FIGO)",
    "definition": "Stage 3A (FIGO) is a designation for cervical cancer characterized by the tumor's invasion into the lower third of the vagina or the pelvic wall, while remaining free of lymphatic or distant metastasis.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "Stage 3A (FIGO)",
    "definition": "Stage 3A (FIGO) refers to a classification of cervical cancer where the tumor has spread to the lower third of the vagina or to the pelvic wall, but not to the lymph nodes or other distant sites.",
    "type": "International Federation of Gynecology and Obstetrics ovarian cancer stage value specification"
  },
  {
    "term": "pM1a (colon)",
    "definition": "pM1a (colon) denotes a category of colon cancer characterized by the presence of distant metastases in one or more regional lymph nodes.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "pM1a (colon)",
    "definition": "pM1a (colon) describes a classification of colon cancer in which there is documented metastasis to one or more lymph nodes in the region.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "pM1a (colon)",
    "definition": "pM1a (colon) refers to a classification of colon cancer where there is evidence of distant metastasis to one or more regional lymph nodes.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "pM1a (colon)",
    "definition": "pM1a (colon) signifies a type of colon cancer that shows signs of metastasizing to one or more regional lymph nodes.",
    "type": "pathologic distant metastases stage for colon according to AJCC 7th edition"
  },
  {
    "term": "pT4b (colon)",
    "definition": "pT4b (colon) denotes a stage in colorectal cancer assessment that signifies the tumor has invaded the visceral peritoneum and has spread to other organs or tissues in the abdominal region.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4b (colon)",
    "definition": "pT4b (colon) is a category in the staging of colorectal cancer that indicates the tumor has breached the visceral peritoneum and has metastasized to various organs or structures in the abdominal cavity.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4b (colon)",
    "definition": "pT4b (colon) refers to a classification in colorectal cancer staging indicating that the tumor has penetrated through the visceral peritoneum and has metastasized to other organs or structures within the abdominal cavity.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "pT4b (colon)",
    "definition": "pT4b (colon) represents a classification in the staging of colorectal cancer, indicating that the tumor has extended through the visceral peritoneum and has disseminated to other abdominal organs or tissues.",
    "type": "pathologic primary tumor stage for colon and rectum according to AJCC 7th edition"
  },
  {
    "term": "J. Mitra",
    "definition": "J. Mitra is a biotech firm focused on creating advanced diagnostic tools for infectious diseases and various health issues.",
    "type": "manufacturer"
  },
  {
    "term": "J. Mitra",
    "definition": "J. Mitra is a biotechnology company specializing in the development of innovative diagnostic solutions for infectious diseases and other health conditions.",
    "type": "manufacturer"
  },
  {
    "term": "J. Mitra",
    "definition": "J. Mitra is a biotechnology enterprise dedicated to the innovation of diagnostic methods for infectious diseases and additional health conditions.",
    "type": "manufacturer"
  },
  {
    "term": "J. Mitra",
    "definition": "J. Mitra operates as a biotechnology organization that emphasizes the creation of cutting-edge diagnostic solutions for infectious diseases and other medical conditions.",
    "type": "manufacturer"
  },
  {
    "term": "pN3 (lung)",
    "definition": "The designation pN3 (lung) pertains to the classification of regional lymph node involvement in lung cancer, indicating that the tumor has spread to multiple lymph nodes on one side of the chest or to those in",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN3 (lung)",
    "definition": "pN3 (lung) denotes the categorization of regional lymph node engagement in lung carcinoma, signifying that the malignancy has disseminated to several lymph nodes on one side of the thorax or to lymph nodes located in the supraclavicular area.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN3 (lung)",
    "definition": "pN3 (lung) is a term used to classify the extent of regional lymph node involvement in lung cancer, suggesting that the disease has metastasized to numerous lymph nodes on the same side of the chest or to nodes in the supraclavicular region.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pN3 (lung)",
    "definition": "pN3 (lung) refers to the classification of regional lymph node involvement in lung cancer, indicating that cancer has spread to multiple lymph nodes on the same side of the chest or to lymph nodes in the supraclavicular region.",
    "type": "pathologic lymph node stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1a (lung)",
    "definition": "The term pM1a (lung) describes the existence of metastatic cancer cells in the lung tissue that have originated from a primary tumor, suggesting a late stage of the disease.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1a (lung)",
    "definition": "pM1a (lung) denotes the occurrence of distant metastases within lung tissue originating from a primary malignancy, signifying an advanced stage of cancer.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1a (lung)",
    "definition": "pM1a (lung) indicates that there are metastatic lesions in the lung that have spread from a primary tumor, reflecting an advanced cancer stage.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "pM1a (lung)",
    "definition": "pM1a (lung) refers to the presence of distant metastasis in the lung tissue from a primary tumor, indicating advanced-stage cancer.",
    "type": "pathologic distant metastases stage for lung according to AJCC 7th edition"
  },
  {
    "term": "domain entity does not exist",
    "definition": "A domain entity does not exist refers to the absence of a specific biological or medical component, such as a gene, protein, or disease, within a given context or dataset.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "domain entity does not exist",
    "definition": "A domain entity not being present indicates that a particular biological or medical element, like a gene, protein, or disease, is lacking in a specific context or dataset.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "domain entity does not exist",
    "definition": "The absence of a domain entity signifies that a particular biological or medical factor, such as a gene, protein, or disease, is not found in a certain context or dataset.",
    "type": "obsolescence reason specification"
  },
  {
    "term": "domain entity does not exist",
    "definition": "When a domain entity is said to be non-existent, it means that a specific biological or medical aspect, including a gene, protein, or disease, is missing from a particular context or dataset.",
    "type": "obsolescence reason specification"
  }
]